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Many top market capitalization companies are information technology (IT) firms, 
including Apple, Google, Microsoft, and Facebook, each of which is valued at more than 
$300 billion.  Facebook is less than 10 years old and is one of the top 10 companies in the 
world in terms of market capitalization.  However, technologies change rapidly; website 
revenue—which once grew at a brisk rate—has slowed down, while mobile technology 
growth is increasing and technology trends are shifting toward cloud hosting and big data 
analytics.  IT companies that have increased their R&D spending remain leaders 
throughout periods of technology change.  Companies such as Facebook and Google 
have doubled and tripled their profits, respectively over` the past decade. In this dynamic 
environment, analysts play a critical role in evaluating IT company financial statements 
and estimating company sales and earnings per share (EPS).   This study examines how 
changes in R&D spending are related to analysts’ sales and earnings estimate revisions.  
An analysis of data over a 20-year period shows that analysts typically revise their sales 
estimates based on changes in a company’s R&D expenditures. The correlation between 
analyst earnings estimates and R&D expenditures, however, varies based on company 
size and industry within the IT sector. Analysts play a particularly important role in small 
companies, where the correlation between R&D and sales changes is not as high as in 
 xii 
large companies. Analysts are thus critical to the functioning of capital markets in the IT 
sector.   
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I CHAPTER 1: INTRODUCTION 
In this research study, I explore whether analysts’ revisions in sales and earnings 
per share (EPS) estimates are related to R&D expenditure changes by technology 
companies.  This issue is of interest to both stock market participants and managers of 
these firms. With the rising pressure to create and sustain competitive advantages through 
technological innovation, IT companies increasingly depend on the efficient management 
of research and development (R&D) activities (Bone & Saxon, 2000).  R&D investments 
are a critical element of growth in firms (Chan, Martin & Kensinger, 1990).  Market 
participants use analysts’ forecasts because analysts process and transform the 
information contained in financial statements—along with additional information about 
the industry, firm strategy, and economy—into future earnings predictions (Wieland, 
2011). Analysts’ forecast revisions promote market price discovery (Gleason & Lee, 
2003) and market participants react to forecast revisions.  
The problem statement for this study is: “What role do technology companies’ R&D 
expenditures play in analysts’ sales and earnings forecasts?” This study zeros in on IT 
companies, extracting records filtered for that sector (group 45) from the Wharton 
Research Data Services (WRDS) Compustat database, with a focus on IT companies that 
have R&D expenditures on their balance sheets.  I extracted analysts’ forecasts for IT 
company sales and EPS for the current and the following year from the Institutional 
Brokers' Estimate System (I/B/E/S) database. 
This research focuses on companies trading in US exchanges.  I categorize companies by 
size into small, midsized, and large based on market capitalization.  I also examine 
various industries within the IT sector; as one study found, R&D intensity that is higher 
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than the particular industry’s average leads to larger stock-price increases for firms in 
high-tech industries (Chan, Martin & Kensinger, 1990). 
I observe that analysts do change their sales forecasts in response to changes in 
R&D expenditures by technology firms.   The relation is robust across three different 
sectors of the IT industry.  Analysts also change their EPS estimates in response to 
changes in R&D, although this relation is not as strong when I consider changes in sales.  
Interestingly, I find that in the smallest capitalization firms, analysts change EPS 
estimates in response to changes in R&D, even when sales changes are considered.  I 
consider this as evidence of the importance of analysts to capital allocation in the 
technology industry.  
The findings I captured during my analysis add to the academic research related 
to R&D expenditure and analyst estimates.  Research spending is heavily concentrated in 
technology and science-oriented industries.  The computer programming, software, and 
services industry represents about 17 percent of the sales and two times the earnings 
compared to other companies in these sectors. Other research (Chan, Lakonishok & 
Sougiannis, 2001) focuses on R&D, but does not concentrate on the analyst aspect.  This 
study will benefit practitioners, allowing them to make smarter investments based on 
R&D expenditure.  Further, analysts’ recommendations on EPS and sales have a 
correlation with stock prices. Huo and Hung (2014) show that stock price drift emerges 
after analysts’ revise their earnings forecasts. 
The study will also benefit managers of technology companies by clarifying how 
analysts make revisions.   For small firms, analysts play a particularly important role, as 
these firms tend to have less market coverage.    
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Analyst forecasts are superior to time-series forecasts because analysts possess 
both an information advantage and a timing advantage (Brown, 1987). Keung’s study 
(2010) finds that earnings forecast revisions supplemented with sales forecast revisions 
have a greater impact on security prices than stand-alone earning forecast revisions. He 
further found that financial analysts are more likely to supplement their earnings forecasts 
with sales forecasts when they have better information.  As Keung’s study discusses in 
detail, supplementary sales forecasts appear to lend credibility to earnings forecasts 
because financial analysts provide better sales forecasts when they are more informed. 
These findings help us understand the characteristics of analysts’ sales and EPS forecasts.  
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II CHAPTER 2: LITERATURE SYNTHESIS 
R&D in technology companies is important for several reasons.   For example, it 
influences executives’ incentives, compensation, and firm performance. Currim, Lim, and 
Kim (2012) found the increase in equity-to-bonus compensation ratio for top executives 
is positively associated with an increase in R&D spending. Further, in their work on 
analyst forecast revisions and market price discovery, Gleason and Lee found a post-
revision price drift associated with these forecast revisions (Gleason & Lee, 2003). Also, 
changes in R&D expenditure in either direction indicate transitions between exploitative 
and exploratory R&D and are associated with increased firm performance (Mudambi & 
Swift, 2014). Such examples illustrate the importance of R&D expenditure and how it 
impacts top executives’ compensation and the stock price performance of firms. 
This association is more intense in high-growth firms and is especially significant 
in the high-tech sector (García-Manjón & Romero-Merino 2012).  This study further 
found that policymakers and business leaders in the high-tech sector maintain R&D 
expenditures even when facing a recession.   Graham and Frankenberger (2008) report 
that increases in R&D spending in recessions increase firm profit and intangible value.  
Even during the recession, companies reduce R&D spending to meet their quarterly 
results, which in turn impacts the growth of the firm. As this literature synthesis shows, 
R&D spending is a key metric for increasing or decreasing firm’s earnings. 
R&D is also important to market participants.   The study by Kumar, 
Charurvedula, Rastogi, and Bang (2009) found that buy recommendations issued by 
analysts help investors generate abnormal returns on the day of the recommendation. On 
the other hand, sell recommendations do not show significant negative abnormal returns. 
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An analyst forecast revision and market price discovery study by Gleason and Lee (2003) 
found that post-revision price drift is associated with analyst forecast revisions.  That 
study documents the following four significant factors:  
1. The market does not sufficiently distinguish between revisions that provide new 
information and revisions that merely move toward the consensus. 
2. The price adjustment process is faster and more complete for celebrity analysts 
than for more obscure yet highly accurate analysts. 
3. The price adjustment process is faster and more complete for firms with greater 
analyst coverage. 
4. A substantial portion of the delayed price adjustment occurs around subsequent 
earnings-announcement and forecast-revision dates.  
The above studies confirm that investors use analyst information for investing in the 
stock market.  Hillary and Hsu (2013) empirically showed that analysts with a lower 
standard deviation of forecast errors have a greater ability to move prices.  These results 
have three implications: 
1. Consistent analysts are less likely to be demoted and more likely to be nominated 
as all-star analysts. 
2. Analysts strategically deliver downward-biased forecasts to increase their 
consistency (sometimes at the expense of stated accuracy). 
3. The benefits of consistency and of “lowballing” (accuracy) are to increase (or 
decrease) the institutional investor’s presence.   
These findings help us understand that analyst reports are used not only by 
individual investors, but also by institutional investors.  
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Fama and French (1992) also found positive abnormal returns associated with high 
Earnings to Price (E/P) stocks, but they found an even stronger relationship between book 
value to price (B/P) ratios and abnormal returns.  Bauman and Dowen (1988) discovered 
mixed results between high growth stocks and stock returns; during their study, they 
found long-term, low growth stocks with low P/E had higher return than higher growth 
stocks with higher P/E. These studies help us to understand the importance of the EPS; 
the Fama and French (1992) study confirms the significance of a company’s earnings for 
the share price being traded.  This literature synthesis illuminates how the investment 
community uses analyst forecast reports.  
Analysts offer significantly greater coverage for firms with larger R&D and 
advertisement expense relative to their industry, as well as for firms in industries with 
large R&D expenses (Barth, Kasniz & McNicholas, 1999). As Figure 1 shows, the US 
National Science Foundation offers a reliable source for R&D trends for US companies 
and government, with a steady transfer of R&D spending from government to the 
business sector.  
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Figure 1 U.S. R&D as Percent of Gross Domestic Product, 1953-2008 
Source – National Science Foundation, (Hirschey et al. 2012) 
Similar to current cash flow, growth, risk, and market share, advertising and R&D 
expenditures are key determinants of a firm’s market value (Chauvin & Hirschey 1993). 
Chauvin and Hirschey’s also found that the market value effects of advertising and R&D 
are broadly operative throughout both manufacturing and nonmanufacturing sectors.  
They suggest that advertising and R&D are an attractive alternative means of investment 
in valuable intangible capital that have differing degrees of relevance in different 
economic sectors.   
Sougiannis (1994) found that, on average, a one-dollar increase in R&D leads to a 
two-dollar increase in profit over a seven-year period, with a five-dollar increase in 
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market value.  Companies with high R&D-to-equity-market value (which tend to have 
poor past returns) earn large excess returns (Chan, Lakonishok & Sougiannis, 2001).   
Analyst accrual and forecast revision strategies generate returns of 15.5 percent and 5.5 
percent, respectively, when implemented independently (Bath & Hutton, 2003). Bath and 
Hutton add that a combined strategy that uses forecast revisions to refine the accrual 
strategy generates a return of 28.55 percent.  They further discuss many studies 
pertaining to analyst earnings forecast; some of these studies argue that analysts don’t 
account for key accounting data (Stober, 1992; Abarbanell & Bushee, 1997). However, 
other studies point out that analyst forecasts are more accurate than time-series models in 
predicting future earnings (Brown, Griffin, Hagerman & Zmijewski, 1987).  Such 
research suggests that analyst forecasts have the potential to give investors value-relevant 
information about earnings (Bath & Hutton, 2003).   
Bath and Hutton note that a second stream of analyst forecast research focuses on 
whether investors actually heed the information in analyst forecast revisions.  Numerous 
studies (e.g., Givoly & Lakonishok, 1980; DeBondt, 1991; Mendenhall, 1991; Stickel, 
1991; Gleason & Lee, 2000; and Elgers, Lo, & Pfeiffer, 2001) have found that analyst 
forecast revisions predict future returns, indicating that investors do not fully utilize the 
information reflected in the forecasts on a timely basis.   
In their study, Hirschey et al. (2012) found that R&D spending continues to grow 
faster than advertising and capital expenditures.  As Figure 2 shows, they found that IT 
companies and small market capitalization companies that spend on R&D increased their 
spending by 57 percent between 1976 and 2010, while non-IT sector companies and large 
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companies (which constitute most of the NYSE) reduced such spending by 12 percent. 
The data in the Figure 2 does not include financial or utilities sector companies.   
 
Figure 2 American Economic Association 
 (Hirshey et al.  2008) 
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Although various studies examine analyst forecasts and R&D, no existing studies 
have examined how R&D impacts analysts’ sales and EPS estimates, nor have 
researcher’s analyzed segmentation based on company size and industry type.   This 
information can be very helpful for practitioners as they consider moving their companies 
into different industry segments or consider buying the stock of IT companies of different 
sizes. This quantitative study will fill this gap and contribute both to practitioners and the 
academic literature.  
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III CHAPTER 3: THEORETICAL BACKGROUND AND HYPOTHESES 
Based on the previous studies in my literature synthesis, it is clear that R&D 
spending has an impact on what aspect of high-tech companies.  Much existing literature 
focuses on analysts and their impact on stock price. Prior studies have shown that 
analysts’ estimates of earnings or sales are quite close to the actual sales and earnings of 
the company—and hence the market reacts when analysts change their estimates. The 
stock’s price moves on the day of an analyst’s revision, especially if that analyst has 
maintained a strong reputation over the years in covering that sector.  In their study, 
Kumar et al.  (2009) found that buy recommendations issued by analysts on public 
domains help investors generate abnormal returns on the day of the recommendation, 
while sell recommendations show no significant negative abnormal returns.  
Analysis done through this quantitative study will expand on the earlier studies 
and focus on the association between the R&D spending and analysts’ sales and EPS 
estimate forecasts. This research will compare the generated results between various 
industries within the IT sector. It will also review the impact of R&D change on analysts’ 
estimate forecasts based on the size of the firms.  Practitioners will benefit from the 
findings through a better understanding of how analysts modify their estimates for 
different industry groupings and company sizes in the IT sector.  Further, by 
understanding how estimates are reflected in the current year versus the next year, 





Hypothesis 1: A change in R&D expenditure impacts analysts’ sales estimate 





Figure 3 Hypothesis 1 
 
Hypothesis 2: A change in R&D expenditure impacts analysts’ sales estimate 




Figure 4 Hypothesis 2 
 
Hypothesis 3: A change in R&D expenditure impacts analysts’ EPS estimate 
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revision for current year 
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Hypothesis 4: A change in R&D expenditure impacts analysts’ EPS estimate 




Figure 6 Hypothesis 4 
 
This study primarily focuses on these four hypotheses, reviewing the correlation 
and regression results of R&D year-over-year expenditure differences associated with 
analysts’ sales and EPS estimates for the current year and the next year. The difference 
between R&D expenditure from the prior to the current year is the independent variable.  
Analysts provide sales or EPS estimates for a company for multiple years based on the 
information they gather during company earning calls and/or through reports filed by the 
company to regulating agencies. The analysts’ sales and EPS estimates for the current 
year and the next year are the dependent variables.   
III.1 Research and Development Expense (R&D) 
According to the Frasacti Manual, “Research and experimental development 
(R&D) comprise creative work undertaken on a systematic basis in order to increase the 
stock of knowledge, including knowledge of man, culture and society, and the use of this 
stock of knowledge to devise new applications” (OECD, 1993). 
R&D covers three activities: basic research, applied research, and experimental 
development.  Basic research is experimental or theoretical work undertaken primarily to 
acquire new knowledge of the underlying foundations of phenomena and observable 











original investigation, undertaken to acquire new knowledge.  It is, however, directed 
primarily toward a specific practical aim or objective.  Experimental development is 
systematic work, drawing on existing knowledge gained from research and/or practical 
experience and directed towards producing new materials, products, and devices; 
installing new processes, systems, and services; or improving substantially those already 
produced or installed (OECD, 1993).   
R&D spending has grown sharply as a percentage of sales.  In 1975, R&D 
expenditure stood at 1.70 percent, but it more than doubled by 1995 to 3.75 percent 
(Chan, Lakonishok & Sougiannis, 2001). R&D expenditure is provided by companies in 
their income statement, which I extracted from the WRDS database for this study. 
III.2 Current Year EPS Estimate Revision 
Current year EPS is defined as the company’s total profit in a fiscal year, divided 
by the number of outstanding shares.  Analysts gather this information based on the 
financial statements, company regulatory filing statements and by interacting with 
company management. Agarwal et al.  (2012) found that earnings forecasts strongly 
respond to macroeconomic releases that signal changes in overall business conditions 
after controlling for analysts’ learning from firm and industry-specific earnings surprises.  
They also found that medium-term forecasts respond much more strongly to 
macroeconomic news than forecasts for the current fiscal year. On average, 
macroeconomic surprises lead analysts to revise their current year earnings forecasts for 
cyclical firms by three cents and the following year’s forecast by five cents.  Such 
revisions might be made when the company’s leadership changes, or when the company 
faces new competition. 
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Analysts develop expertise in obtaining and analyzing information from various sources, 
including the following: 
 Earnings and other information from SEC filings, such as proxy 
statements and periodic financial reports   
 Industry and macroeconomic conditions 
 Conference calls and other management communications   
Using this information, analysts produce earnings forecasts, target price forecasts, 
and stock recommendations, along with qualitative reports describing a firm’s prospects. 
Ramnath (2002) showed that analysts revise their earnings forecasts in response to the 
earnings announcement of other firms in the same industry.  Based on the above studies, I 
can confirm that analysts include specific industry and/or market sector factors in their 
earnings forecasts.  EPS is also impacted when there is an increase in advertisement 
spending, as it will attract more customers.  With additional customers, the firm’s 
revenues will rise, which in turn increases the bottom line of the company. 
 16 
 
Figure 7 Input to Analyst Report 
(Ramnath, Rock, Shane 2003) 
III.3 Next Year EPS Estimate Revision 
Next year EPS is defined as the profit a company generates per share in the 
following year. Analysts update this estimate at the same frequency as they update their 
current year EPS; the factors that impact the current year EPS estimates might also 
impact the next year EPS estimates.  However, in some scenarios, the current year EPS 
might be reduced, while the next year EPS is increased.  For example, a company might 
spend more on advertising in the current year to market a new product, reducing 
advertising in the year following, which will increase the EPS estimate for that following 
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year.  Also, the next year’s EPS estimate might be revised up, as the resources hired to 
support the new product might not be needed in the following year. As the new product 
stabilizes, customer support will be reduced, which improves the EPS of the organization. 
III.4 Current Year Sales Estimate Revision 
The current year sales forecast is defined as the company revenue that analysts 
predict for the current year.  Analysts’ forecasts and the revisions that follow influence 
price-relevant trades (Givoly & Lakonishok, 1979; Lys & Sohn, 1990; Park & Stice, 
2000).  Analysts’ estimating activities should cause prices to reflect the market and 
industry information, resulting in larger return synchronicity (Piotroski & Roulstone 
2003). Clement (1999) and Jacob, Lys, and Neale (1999) found that analyst accuracy 
improves with industry specialization, while Gilson et al. (2001) illustrated that the 
analyst coverage composition is impacted after spin-offs and equity carve-outs. 
The macro economy also plays an important part in analysts’ sales estimates.  For 
example, when consumer confidence falls, people reduce their spending, which impacts a 
company’s revenue. Also, when the companies are not hiring and wages stagnate, 
consumer spending also declines, which also impacts a company’s sales. When jobs are 
impacted, people delay buying computers, software, and other technology products that 
impact computer manufacturers and software development companies.  The same is true 
for corporations: companies review the outlook of the economy and decide on their 
spending; if the outlook is bleak, they postpone capital purchase for few years and wait 
for market conditions to improve. Corporate analysts thus revise their revenue forecasts 
for technology companies based on job market conditions, consumer confidence, and 
economic outlook.   
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Historically, the technology industry has experienced considerable disruption. 
Blackberry—once the leader in the smart phone industry—was replaced by Apple and 
Samsung, while Yahoo’s leadership in search engine and email technology was usurped 
by Google.  Analysts thus look at the industry, review the competition in various areas, 
and revise the revenue forecasts for companies accordingly.   
III.5 Next Year Sales Estimate Revision 
Analysts’ next year sales estimate forecasts are defined as the revenue a company 
is expected to make the following year. Analysts update their estimates for the next year 
at the same frequency as they update their sales estimate forecasts for the current year, as 
factors that impact the current year’s sales might also impact those of the following year.  
Similar to EPS, the next year’s sales estimate might differ from the current year’s sales 
estimate. New product launches or new marketing initiatives might influence next year’s 





IV CHAPTER 4: DATA COLLECTION AND ANALYSIS 
For this research, I extracted two sets of data from the WRDS website:  
 R&D expenditure and company-related information 
 Analyst estimate information 
I extracted the R&D expenditure and company-related information from the 
Compustat database. Because my research focuses on the IT sector, I specifically 
extracted the data pertaining to this sector by querying the database with Global Industry 
Classification (GIC) sector code 45.  I gathered the R&D/company-related data from the 
yearly database section, which annually consolidates this data for IT companies.   
I extracted analyst estimates from the WRDS IBES database for the following categories: 
 Sales estimate for the current year (“1st year” as per WRDS database)  
 EPS estimate for the current year 
 Sales estimate for the next year (“2nd year” as per WRDS database)  
 EPS estimate for the next year 
Most analysts make changes to their estimates following the company’s quarterly 
earnings release; analysts attend the quarterly earnings release conference and ask 
questions needed to update their forecast estimate.  Their questions typically focus on the 
existing quarterly results, as well as the company’s forecast in terms of sales, earnings, 
expenditure on advertisement, and R&D. This information gives them the input needed to 
model their earnings estimate forecasts for sales and EPS. After gathering this 
information, analysts generate a detailed report about the target company. In that report, 
they cover the company’s future sales, earnings, and ideal stock price, and offer a 
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recommendation to buy, sell, or hold the stock.  Finally, some analysts change their 
estimate forecasts in the wake of macro information or changes related to the company.  
 Although analysts publish their estimates about a target company on different days in a 
month, the IBES database consolidates the information on a monthly basis.  Because 
multiple analysts cover particular stocks—typically those of large or popular 
companies—in a given month, multiple analysts might change their estimates.  I thus use 
the median information for this study.  
The data I collected for R&D expenditures and analyst estimates is for 20 years, 
from 1995 to 2014.  I extracted the data in Excel format from the Compustat and IBES 
databases.  I then cleaned the data in the Excel database before loading it into IBM 
Statistical Package for Social Sciences (SPSS). I extracted data related to all IT 
companies, but not all such companies have R&D expenditures so I filtered out those 












Table 1 R&D and Company-Related Information 
Data extracted Description of the data. 
Stock Symbol Symbol representing the stock, (Apple, symbol will 
be AAPL, Microsoft MSFT) 
Fiscal year Financial year (1995, 1996….) 
Company Name Full name of the company, Apple will be Apple 
INC, IBM will be INTL BUSINESS MACHINES 
CORP 
Revenue Total revenue for the year. 
Asset Total Asset the company reported during end of 
their financial year in their reports. 
Gross Profit Profit company makes after deducting the costs 
associated with making and selling its products 
R&D spending for current year Research and development spending for the current 
year  
R&D spending for prior year Research and development spending for the prior 
year 
Long-term debt Debt obligations such as bank loans, mortgage, 
bonds which matures more than one year 






I calculated the following information using the data in Table 1: 
 Gross margin: gross profit/revenue 
 The gross margin data point (used during the regression)  
 Debt-to-sales: long-term debt/revenue 
 The debt-to-sales data point (used during the regression) 
 Revenue difference: the revenue for the current year minus the revenue for the 
prior year 
 Revenue difference percentage: revenue difference/revenue for prior year 
Because the revenue for the prior year is not available in the WRDS, I derived it 
from the previous year’s data using Excel advanced programming.   
I generated the second set of data from the IBES database. 
Table 2 Analyst Data from IBES 
Data extracted from IBES database 
Symbol 
Period end data 
Measurement (EPS or Sales) 
Forecast period (1 – current year, 2 – Next year) 
Median estimate 
 
I extracted the IBES data pertaining to analyst estimates into Excel as monthly 
summary data, then transformed it into analysts’ beginning of the year and end of the 
year estimates.  I did this using Excel functions and pivot tables.  A company’s starting 
month and ending month are identified at the start of the data construction process; such 
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information varies among companies as they have different fiscal year closing months 
(most companies use December as the fiscal year closing month, but some use March, 
June, or September). 
I used advanced Excel functions to calculate analyst data in four areas—current 
year sales percentage, next year sales percentage, current year EPS percentage, and next 
year EPS percentage—then merged the data with the records generated from the 
Compustat database. The R&D data, company data, and analyst data are normalized into 
a single record for each company per calendar year.  For example, for IBM, there is one 
record per year from 1995 to 2014; this contains all the data needed for my analysis.  The 
data massaged in Excel is then uploaded and analyzed in SPSS software.  
Table 3 Data Calculated and Consolidated in Excel Spread Sheet 
Data consolidated in Excel spread sheet 
Analyst Sales estimate forecast for current year 
Analyst Sales estimate forecast for Next year 
Analyst EPS estimate forecast for current year 
Analyst EPS estimate forecast for Next year 
Analyst Sales estimate forecast percentage change for current year  
Analyst Sales estimate forecast percentage change for Next year  
Analyst EPS estimate forecast percentage change for current year  






IV.1 Distribution of Samples over Time, by Size and by Industry 
IV.1.1 Time  
The data in Table 4 provides the year-wise breakup of the number of companies 
in each calendar year for this study. This research is a 20-year study of IT companies, 
with data gathered for the years 1995 to 2014. The records identified are for companies 
that had R&D expenses allocated in their balance sheets that were also covered by 
analysts.  The number of companies in Table 4 for each calendar year increased from 
1995 to 1999, then, following dot-com burst, the number declined, as many technology 
companies went bankrupt. After the dot-com crash, the market value of many companies 
decreased dramatically, and many were either bought by or merged with other (often 
larger) companies.  In 2000, 526 companies IT companies had R&D allocations on their 
income statements and were covered by analysts.  In 2013, the number declined to 327—
a reduction of 199 companies over 13 years due to bankruptcy, mergers, or purchase by 

















1995 301 3.8 
1996 387 4.9 
1997 413 5.2 
1998 423 5.4 
1999 462 5.8 
2000 526 6.7 
2001 489 6.2 
2002 448 5.7 
2003 407 5.2 
2004 407 5.2 
2005 392 5.0 
2006 378 4.8 
2007 398 5.0 
2008 363 4.6 
2009 346 4.4 
2010 337 4.3 
2011 339 4.3 
2012 332 4.2 
2013 327 4.1 
2014 341 4.3 
 
IV.1.2 Size 
Market capitalization data provides company size: the larger the market 
capitalization, the larger the company. The firms are divided into three categories 
according to their market capitalization: 
 Large: greater than or equal to $10 billion (USD) 
 Midsized: greater than $1 billion, but less than $10 billion 
 Small: less than $1 billion 
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I categorize the data to show how analysts capture R&D expenditure changes in 
their estimate forecasts. Large companies (greater than $10 billion) are covered by more 
analysts; typically those companies have been in business for a long time and have grown 
over the years.  Small companies (less than $1 billion) are typically newer firms that are 
covered by fewer analysts. 
IV.1.3 Industry 
After extracting data for the IT sector using GIC sector code 45, three industry 
groupings emerged as identified by GIC group codes: Software and Services (which had 
the most records), Technology Hardware and Equipment, and Semiconductor. 
Table 5 Industry Grouping 
GIC group code Description of the group 
4510 Software and Services 
4520 Technology Hardware and equipment 
4530 Semiconductor 
 
IV.1.3.1 Software and Services group 
The Software and Services group encompasses application software, systems 
software, Internet software and services, data processing and outsourced services, IT 
consulting, and home entertainment software companies. As Table 6 shows, this group 
had the most records (3,074). 
IV.1.3.2 Technology Hardware and Equipment 
The Technology Hardware and Equipment group consists primarily of 
communications equipment, computer hardware, computer storage and peripherals, 
electronic equipment and instruments, electronic components, electronic manufacturing 
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services, technology distributors, and office electronics companies.  This group had 2,961 
records (see Table 6). 
IV.1.3.3 Semiconductor  
The Semiconductor group is made up of semiconductor and semiconductor 
equipment firms, and was once part of the Technology Hardware and Equipment group.  
It had the fewest number of records, with 1,863 (Table 6). 
Table 6 Number of Records Industry Wide 
Type of industry No of Records Percentage 
Software and Services 3074 38.9 
Technology Hardware and equipment 2961 37.5 
Semiconductor 1863 23.6 
 
Table 7 shows the industry groupings, sub-industry descriptions, and sample 












Table 7 Sub Industries and Company Examples. 
Industry Sub Industries description Examples of 
companies in these 
industry 
Software and Services Internet Software & Services Yahoo, AOL, 
 IT consulting and other services Teradata, IBM 
 Data processing and outsourced 
services 
Xerox 
 Application Software Intuit, Adobe systems 
 Systems Software Oracle, Microsoft 
 Home Entertainment Software Take-Two, Zynga 
Technology Hardware 
& equipment 
Communications Equipment Cisco, Qualcom 
 Computer Hardware Dell 
 Computer Storage and Peripherals Apple, Sandisk 




 Electronic Components Corning 
 Electronic Manufacturing Services Flextronics 
 Technology distributors Richardson electronics 
 Office electronics General Scanning 
Semiconductor Semiconductor Equipment Lam Research, 
Teradyne 
 Semiconductors Texas Instrument, First 
solar 
 
IV.2 Data analysis 
A single record for each company per fiscal year was created in Excel and imported into 
SPSS to generate the results.   Separate results were generated for analysts’ sales 
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estimates and analysts’ EPS estimates; to show analysts’ estimate changes for current 
year and next year, I ran the tests separately for each of those years.   
A summary of the analysis done in SPSS to generate the results is as follows: 
 Descriptive statistics were generated for all variables used in this study. 
 A correlation matrix was generated for all independent variables and for 
different market capitalization companies. 
 Correlation tests were performed to identify the association between R&D 
spending and the changes in analysts’ current year sales estimates; these tests 
were run for the three different industry groups and for the three different 
company sizes.  A correlation test was also run for R&D spending increases 
that were greater than five percent (eight tests were performed in this 
category). 
 Correlation tests were performed to identify the association between R&D 
spending and changes in analysts’ next year sales estimates, as well as the 
above-mentioned six segment tests and those for R&D spending increases 
greater than five percent (eight tests were also performed in this category). 
 Correlation tests were performed to identify the association between R&D 
spending and analysts’ current year EPS estimates, along with the same six 
segment tests and those for R&D spending increases greater than five percent 
(again, eight tests were performed in this category). 
 The same correlation tests were performed to identify the association between 
R&D spending and changes in analysts’ next year EPS estimates.  
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 Regression tests were run on five independent variables—R&D spending 
differences, revenue differences, assets log, long-term debt/sales, and gross 
margin— association with changes in analysts’ current year sales estimates. 
As with correlation, regression tests were run for the three industry groups and 
three company sizes, as well as for R&D spending increases greater than five 
percent.  I also ran an additional test without revenue difference regression 
(performing nine regression tests in this category). 
 Regression tests were run on the five independent variables association with 
changes in analysts’ next year sales estimates, the six segmentation tests, 
R&D greater than 5 percent, and regression without revenue differences (nine 
tests). 
 The same regression tests were performed with the above-mentioned 
independent variables association with changes in analysts’ current year EPS 
estimates.  
 The same regression tests were performed with the above-mentioned 
independent variables association with changes in analysts’ next year EPS 
estimates. 
Overall, 32 correlation and 40 regression tests were conducted to analyze the four 
different hypotheses in this study. The outcomes of these tests will help to determine 




V CHAPTER 5: RESULTS 
V.1 Descriptive Statistics 
Table 8 shows summary statistics of data gathered for 7,900 samples related to IT 
firms with group ID 45. The variable assets, gross profit (loss), long-term debt, revenue, 
gross margin, research and development current year, research and development prior 
year, and market value were extracted from the Compustat database. Revenue prior year, 
revenue difference, revenue difference percentage, R&D difference, and R&D difference 
percentage were calculated.   
I extracted analysts’ current and next year EPS estimates from the end and the beginning 
of each year from the IBES database.   I extracted the same data for analysts’ sales 
estimates from IBES.  The actual difference and the difference in percentage variables for 






Table 8 Descriptive Statistics 
 Minimum Maximum Mean Std.  Dev 
Assets – Total 0.03 290479.00 1990.70 10510.24 
Gross Profit (Loss) -719.76 104126.00 756.84 4213.38 
Long-term debt 0.00 39959.00 232.63 1572.32 
Revenue     
      Revenue current year 0.00 233715.00 1430.16 7936.83 
      Revenue Prior year 0.00 182795.00 1518.93 7873.99 
      Revenue difference -12519.00 50920.00 114.47 1293.41 
      Revenue difference percentage -1.00 65.87 0.20 1.14 
Gross Margin -141.41 1.00 0.38 3.49 
Market Value - Total - Fiscal 0.60 626550.35 5072.62 28018.82 
Research & Development     
      Research & Development Expense 0.00 12128.00 146.98 675.72 
      Research & Development Prior year 0.00 11537.00 134.53 629.37 
      Research spending difference -1595.00 2209.00 12.45 94.22 
      Research difference percentage -1.00 345.84 0.36 4.31 
 Analyst estimate current year EPS  end of 
the year 
-645.00 53.20 0.00 9.33 
 Analyst estimate current year EPS  
beginning of the year 
-510.00 57.00 0.32 7.04 
 Analyst estimate current year EPS 
difference 
-318.20 27.75 -0.32 5.00 
 Analyst estimate current year EPS 
difference % 
-116.25 205.00 -0.18 4.75 
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 Analyst estimate next year EPS end of the 
year 
-141.43 58.50 0.61 3.52 
 Analyst estimate next year EPS beginning 
of the year 
-276.57 75.60 0.84 4.88 
 Analyst estimate next year EPS difference -106.41 188.00 -0.23 3.60 
 Analyst estimate next year EPS difference 
% 
-81.00 63.00 -0.20 2.56 
Analyst estimate current year sales end of 
the year 
0.00 233139.50 1597.31 8441.96 
Analyst estimate current year sales  year 
beginning of the year 
0.00 210730.00 1616.93 8447.77 
Analyst estimate current year sales 
difference 
-22608.30 22409.50 -19.63 780.76 
Analyst estimate current year sales 
difference % 
-1.00 14.00 -0.02 0.30 
Analyst estimate next year sales current year 
end of the year 
0.00 245433.00 1775.64 9216.57 
Analyst estimate next year sales current year 
beginning of the year 
0.60 224865.00 1844.63 9340.82 
Analyst estimate next year sales difference -85452.37 33495.50 -68.99 1726.58 
Analyst estimate next year sales difference 
% 
-1.00 5.87 -0.03 0.29 
logofassets -3.38 12.58 5.53 1.74 
Long-term debt/sales 0.00 2.03 0.07 0.13 
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V.2 Correlation Matrix of Independent Variables 
I generated the correlation matrix for all the variables used in the regressions.  
The matrix shows which independent variables are strongly correlated and which are not 
correlated.  As Table 9 shows, the research difference percentage is strongly correlated 
with the revenue difference percentage.  The correlation between research spending 
difference and revenue difference is .205, with .000 significance.  

























X -.011 .205 -.018 -.005 
Sig.  (2-
tailed) 
  .317 .000 .117 .651 
N 





-.011 X -.019 .221 -.004 
Sig.  (2-
tailed) 
.317   .122 .000 .746 








.205 -.019 X -.012 -.026 
Sig.  (2-
tailed) 
.000 .122   .336 .033 





-.018 .221 -.012 X .073 
Sig.  (2-
tailed) 
.117 .000 .336   .000 





-.005 -.004 -.026 .073 X 
Sig.  (2-
tailed) .651 .746 .033 .000   
N 7881 7753 6647 7881 7881 
Notes : Correlation Matrix between all independent variables used in regression.  
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In Table 10, the correlation matrix shows the results generated for the companies 
with market capitalization greater than or equal to $10 billion.  As with Table 9’s results, 
the research difference percentage is strongly correlated with the revenue difference 
percentage. The correlation between research spending difference and revenue difference 
is .586, with .000 significance. This is much higher than the correlations for the sample at 
large, indicating that large companies exhibit a very strong relationship between R&D 
and sales changes.  All other independent variables are negatively correlated to the 
research difference percentage. 
Table 10 Correlation Matrix for Large Size Firms 
























X -.122 .586 -.321 -.095 
Sig.  (2-
tailed) 
  .013 .000 .000 .051 
N 





-.122 X .030 .176 -.076 
Sig.  (2-
tailed) 
.013   .555 .000 .121 








.586 .030 X -.366 .116 
Sig.  (2-
tailed) 
.000 .555   .000 .018 





-.321 .176 -.366 X -.085 
Sig.  (2-
tailed) 
.000 .000 .000   .079 









.051 .121 .018 .079   
N 424 412 413 424 424 
In Table 11, the correlation matrix illustrates the results for companies with less 
than $10 billion and more than $1 billion in market capitalization. Similar to large 
companies, the research difference percentage is strongly correlated with the revenue 
difference percentage. The correlation between research spending difference and revenue 
spending is .627.  
Table 11 Correlation Matrix for Medium Size Firms 
























X -.092 .627 -.201 -.069 
Sig.  (2-
tailed) 
  .000 .000 .000 .004 
N 





-.092 X -.095 .298 -.017 
Sig.  (2-
tailed) 
.000   .000 .000 .487 








.627 -.095 X -.269 -.107 
Sig.  (2-
tailed) 
.000 .000   .000 .000 





-.201 .298 -.269 X -.023 
Sig.  (2-
tailed) 
.000 .000 .000   .336 





-.069 -.017 -.107 -.023 X 
Sig.  (2-
tailed) 
.004 .487 .000 .336   
N 1716 1693 1580 1716 1716 
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In Table 12, the correlation matrix shows results for companies with market 
capitalization that is less than or equal to $1 billion.  Although these results show that the 
research difference percentage is correlated with revenue difference percentage, the 
correlation is not as strong as it is for companies with more than $1 billion in market 
capitalization. The correlation between research spending difference and revenue 
spending is .167 although this is much lower than in large companies. All other 
independent variables are not significant at normal levels. 
Table 12 Correlation Matrix for Small Size Firms 






















X -.016 .167 .001 -.016 
Sig.  (2-
tailed) 
  .294 .000 .969 .280 





-.016 X -.010 .190 -.005 
Sig.  (2-
tailed) 
.294   .536 .000 .727 







.167 -.010 X .009 -.026 
Sig.  (2-
tailed) 
.000 .536   .566 .100 
N 3894 3849 3894 3894 3891 
Log of Assets Pearson 
Correlation 
.001 .190 .009 X .095 
Sig.  (2-
tailed) 
.969 .000 .566   .000 
N 4473 4399 3894 4473 4458 
Gross Margin Pearson 
Correlation 
-.016 -.005 -.026 .095 X 
Sig.  (2-
tailed) 
.280 .727 .100 .000   
N 4458 4387 3891 4458 4458 
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I analyzed sales estimate forecasts and research spending, then followed the same 
procedure for the EPS estimates. Within the sales tests, I analyzed both the current year 
and the following year. The tests were initially focused on all IT companies; I then drilled 
down into market size and industry segments.   
V.3 Hypothesis 1: A change in R&D expenditure impacts analysts’ sales 
estimate forecasts for the current year. 
To test this hypothesis, a correlation test was performed between the R&D 
spending difference percentage and the analysts’ sales estimates difference percentage for 
the current year (see Table 13). 
Table 13 Correlation R&D and Analyst Sales Estimate 
Years Sector description Pearson 
Correlation 
Sig N 
Current year estimate All IT companies .153 .000 6830 
Next year estimate All IT companies .183 .000 6690 
Notes: Correlation of Analyst Sales estimate percentage difference (dependent 
variable) with R & D expenditure percentage difference (independent variable) 
 
As Table 13 shows, there is a positive correlation between R&D expenditure and 
analysts’ sales estimates for the current year. The Pearson correlation is .153, with .000 
significance (Table 13); the number of records used for the current year analysis was 




V.4 Hypothesis 2: A change in R&D expenditure impacts analysts’ sales estimate 
forecasts for the next year.   
To test this hypothesis, I performed correlation analysis for the next year (Table 
13). The results show a correlation between R&D expenditure and analysts’ sales 
estimates. The Pearson correlation is .183, with .000 significance; the number of records 
used for the next year analysis was 6,690. Based on the correlation results, Hypothesis 2 
is also supported. 
Although the correlation tests support hypotheses 1 and 2, I conducted regression 
tests to confirm whether changes in R&D have a major influence on changes to analysts’ 
sales estimates.  I executed the regression tests using the five independent variables—
R&D expenditure difference percentage, gross margin, log of assets, revenue difference, 
and long-term debt/sales—with the dependent variable being analysts’ sales estimate 
percentage difference.   
Table 14 Regression of R&D, Revenue, … with Analyst Sales Estimate 
















.075 .000 98.09 .221/.000 .006/.607 .095/.000 .092/.000 -.015/.242 
Next year 
estimate 
.069 .000 87.99 .159/.000 .005/.686 .123/.000 .142/.000 -.007/.575 
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Notes : Regression of  Independent variables (R&D expenditure percentage 
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term 
debt/sales) with Analyst sales estimate percentage difference (dependent variable). 
For the current year, the R2 value is .07; reviewing the standards coefficient beta 
values shows that research spending difference has the highest influence in the regression 
with .221 and .000 significance (Table 14).  The revenue difference percentage standard 
coefficient beta value is .092, with .000 significance, and the asset log is .095, with .000 
significance, which illustrates that these independent variables also influence the 
regression. Other independent variables did not prove significant in this regression.   
For the next year, the regression results (Table 14) are quite similar to the current year, 
with R2 at .069.  In the next year results, research spending is the highest contributing 
independent variable: .159, with .000 significance.  Similar to the current year, in the next 
year, both revenue difference and assets have a positive coefficient beta value, with .000 
significance. 
I further analyzed the analysts’ sales estimate percentage difference and R&D 
expenditure percentage difference based on company size.  For all three categories, the 
current year and next year correlations are positive and the significance is .000 (see Table 
15). For companies with $10 billion or more in market value for the current year, the 
correlation is quite strong: .569, with .000 significance and a sample size of 421.  The 
sample size increases for companies with less than $10 billion in market capitalization; it 
increases even more for companies with less than $1 billion in market capitalization.  For 
current year analyst sales estimates for companies with market capitalization of more 
than $1 billion and less than $10 billion, the correlation is .350 with a significance of .000 
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and a sample size of 1,685. For companies with less than $1 billion in market capital, the 
current year correlation is not as strong as in other results, but still has a positive 
correlation of .128, with significance of .000 and a sample size of 4,502. 
The correlation for analysts’ next year sales estimate differences and the R&D 
spending differences follows a pattern identical to the current year results. The 
correlation is stronger for larger market capitalization companies.  The next year results 
reveal that, for companies with $10 billion in market value, the correlation is strong: .479, 
with .000 significance.  The sample size for this analysis is 421 (the sample size increases 
as the market value decreases, similar to the current year pattern).  For companies with 
market capitalization greater than $1 billion and less than $10 billion for the next year, 
the correlation is .361, with a .000 significance and a sample size of 1,674. For firms with 
a market capitalization of less than $1 billion, the correlation between the analysts’ next 
year sales estimates and the R&D spending difference is not as strong as in other 
segments: the correlation value is .128, with .000 significance and a sample size of 3,969. 
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Table 15 Correlation of R&D with Analyst Sales – Market Cap Segmentation 
Years Market value Pearson 
Correlation 
Sig N 
Current year estimate >=10 billion .569 .000 421 
Current year estimate >1 billion & 
<10billion 
.350 .000 1685 
Current year Estimate =< 1 billion .128 .000 4502 
Next year Estimate >=10 billion .479 .000 421 
Next year Estimate >1 billion & 
<10billion 
.361 .000 1674 
Next year Estimate =< 1 billion .102 .000 3969 
Notes: Market cap wise correlation of Analyst Sales estimate percentage 
difference (dependent variable) with R & D expenditure percentage difference 
(Independent variable). 
Positive correlation exists for all results in Table 15; to confirm that R&D 
expenditures are the major influencer for analysts to update their sales estimate, 
regression tests were performed. The regression results in Table 16 demonstrate that R2 is 
65 percent, but that research spending is not significant in this regression.  Other values 
also are not significant in this regression, apart from the revenue difference percentage, 
which had a strong coefficient value of .839. The same pattern is observed in the next 
year estimate results: R2 is 37 percent, the research spending standard coefficient beta is –
.009, with .851 significance.  The results show that, in the current year, the revenue 
percentage difference’s standard coefficient beta is .636, with .000 significance. 
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Table 16 Regression of R&D, Revenue, … with Analyst Sales Estimate (Large Size 
companies) 
















.657 .000 150.2 -
.020/.583 
-.024/.434 .047/.151 .839/.000 .020/.513 
Next year 
estimate 
.379 .000 47.95 -
.009/.851 
-.030/.468 .047/.285 .636/.000 .034/.400 
Notes : Regression of  independent variables (R&D expenditure percentage 
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term 
debt/sales) with Analyst Sales estimate difference percentage for companies with 
market capitalization >= 10 billion. 
 
As Table 17 shows, for companies with market capitalization greater than $1 
billion and less than $10 billion, the results are similar to companies with market 
capitalization greater than $10 billion.  In Table 17, R2 is 49 percent with an F value of 
299, but research spending is negatively correlated, with significance higher than .005. 
The other variables in this regression are not significant, apart from revenue difference 
percentage, which is significant with the coefficient value of .722.  
The same pattern occurs in the next year estimate results (Table 17), where R2 is 
65 percent; the research spending standard coefficient beta is not significant, but the 
revenue percentage difference standard coefficient beta is .636, with .000 significance. 
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Table 17 Regression of R&D, Revenue, … with Analyst Sales Estimate (Medium 
Size companies) 























.649 .000 222 .016/.524 -.104/.000 .006/.772 .622/.000 .012/.568 
Notes : Regression of  independent variables (R&D expenditure percentage 
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term 
debt/sales) with Analyst Sales estimate difference percentage for companies with 
market capitalization < 10 billion and market capitalization > 1 billion. 
 
The pattern changes for companies with market capitalization of $1 billion or less.  
In this segment, the research spending estimate difference has the highest standard 
coefficient beta value of the independent values at .217, with a .000 significance.  The 
value for next year research spending estimate difference standard coefficient beta is 
.103. In both current year and next year, the R2 is .05 and .02, respectively, and the F 
values are 42.20 and 16.8, respectively, with .000 significance. Gross margin and long-
term debt sales values (Table 18) are not significant, and revenue difference percentage is 
significant only in the next year results section.  Assets values are significant at .059 for 
the current year and .068 for the next year.   
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Table 18 Regression of R&D, Revenue, … with Analyst Sales Estimate (Small size 
companies) 
















.055 .000 42.20 .217/.000 .003/.863 .059/.000 .029/.079 -0.14/.381 
Next year 
estimate 
.024 .000 16.8 .103/.000 .001/.955 .068/.000 .074/.000 -.011/.534 
Notes : Regression of  independent variables (R&D expenditure percentage 
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term 
debt/sales) with Analyst Sales estimate difference percentage for companies with 
market capitalization < 1 billion. 
  
Table 19 shows the analysts’ sales estimates percentage difference compared to 
the R&D expenditure difference based on the IBES database’s three GIC industry 
groupings: Software and Services, Technology Hardware and Equipment, and 
Semiconductor.  As in all three company size categories, for current year and next year 
the correlation is positive for all three industry groups, with a .000 significance. For 
Software and Services firms, the correlation is strong and significant with .210 and the 
sample size of 2,719.  
The sample size is the largest for Software and Service group.  Correlation results 
for Technology and Hardware companies for the current year analyst sales estimate 
difference compared to R&D expenditure difference is .088, with .000 significance and a 
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sample size of 2,458. The sample size for the current year Semiconductor category is 
1,683—the smallest of the three sectors—yet the correlation is still significant at .136.   
The next year’s results for the industry groups demonstrate the association of 
analysts’ sales estimate percentage difference to R&D expenditure difference: the 
correlation for Software and Services is .205, with .000 significance and a sample size of 
2,657.   For Technology Hardware and Equipment, the correlation with the same 
constructs is .211, with .000 significance and a sample size of 2,369.  As with the current 




Table 19 Correlation of R&D with Analyst Sales – Industry Group Segmentation 





Software and Services 
(4510) 
.210 .000 2719 
Current year 
estimate 
Technology Hardware and 
equipment (4520) 






.136 .000 1683 
Next year 
estimate 
Software and Services 
(4510) 
.205 .000 2657 
Next year 
estimate 
Technology Hardware and 
equipment (4520) 






.120 .000 1664 
Notes: Industry wise correlation of Analyst Sales estimate percentage difference 
(dependent variable) with R & D expenditure percentage difference (independent 
variable). 
 
Table 20’s regression results for Software and Services shows that R2 is .08, but 
the research spending standard coefficient beta is positive at .235, with significance 
below .01. For the revenue difference percentage and assets log, the coefficient values are 
both significant at .106 and .057.  The next year results are identical to the current year 
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results, where R2 is .11 with an F value of 60.11 and .000 significance. The research 
spending standard coefficient beta is positive at .168, while the revenue difference and 
assets log are at .229 and .130, respectively, and all three values have a significance of 
less than .01.  Other values are not significant in this regression. 
Table 20 Regression of R&D…… with Analyst Sales Estimate (Software & Services) 
















.083 .000 41.92 .235/.00 .004/.860 .057/.005 .106/.000 .001/.960 
Next year 
estimate 
.118 .000 60.11 .168/.00 .008/.697 .130/.000 .229/.000 .007/.734 
Notes: Regression of independent variables (R&D percentage difference, Ratio of 
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst 
sales estimate percentage difference (dependent variable) for Software and Service 
industry group. 
 
In the Hardware and Equipment group, the regression results illustrate that the 
standard coefficient beta for the current year is .195; for the next year, the value is the 
same, with a .000 significance for both years.  The analysis for current year results 
showed no significance value for revenue difference, but the gross margin and asset log 
values are significant, with coefficient values of .061 and .025, respectively. Results for 
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the next year reveal that, apart from research spending and long-term debt/sales, all other 
values are not significant. 
 
Table 21 Regression of R&D…… with Analyst Sales Estimate (Technology 
Hardware) 
















.073 .000 34.48 .195/.000 .061/.004 .159/.000 .025/.227 -.001/.962 
Next year 
estimate 
.60 .000 27.09 .195/.000 .045/.035 .113/.000 .044/.041 .027/.218 
Notes: Regression of independent variables (R&D percentage difference, Ratio of 
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst 
sales estimate percentage difference (dependent variable) for Technology Hardware 
industry group. 
 
Finally, in the Semiconductor Equipment group (Table 22), the results show that 
research spending values are not significant. In both years, the revenue difference has a 
significant standard coefficient value of .494 and .390. The R2 is 51 percent for the 
current year and 16 percent for next year. 
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Table 22 Regression of R&D……with Analyst Sales Estimate (Semiconductor) 
















.516 .000 112.8 -
0.43/.064 
.08/.000 .117/.000 .494/.000 -.038/.092 
Next year 
estimate 
.166 .000 61.16 -
0.19/.436 
.007/.769 .119/.000 .390/.000 .030/.217 
Notes: Regression of independent variables (R&D percentage difference, 
Ratio of gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with 
Analyst sales estimate percentage difference (dependent variable) for semiconductor 
industry group. 
 
The correlation and regression results for the analysts’ sales estimate percentage 
difference compared to the R&D percentage difference primarily shows a positive 
correlation; a few results are negative in regression but not significant.  The next few 
tables show results for analysts’ EPS estimate revisions for the current year and the next 
year; these results were gathered using correlation and regression tests.   
For EPS, I applied a filter on the analysts’ EPS estimate percentages that were 
greater than –100 percent or less than 100 percent to avoid data outliers. Also, a few 
records had more than 9,000 percent positive or negative differences.  These high 
percentage differences were due to the EPS estimate change from a negative value at the 
beginning of the year to a positive value at the end of the year, or vice versa.   Filtering 
 51 
greater than –100 percent and less than 100 percent removed these extreme values and 
reduced the data sample size by 5 percent. 
V.5 Hypothesis 3: A change in R&D expenditure impacts analysts’ EPS estimate 
forecasts for the current year.   
The correlation results (Table 23) for all IT companies between analysts’ EPS 
estimate differences and R&D differences do not show a significant value for the current 
or next year; the current year sample is 6,387 and its correlation is positive at .008, but it 
is not significant (the significance value is .536). 
Table 23 Correlation R&D with Analyst EPS Estimate 
Years Sector description Pearson 
Correlation 
Sig N 
Current year estimate All IT .008 .536 6387 
Next year estimate All IT .021 .084 6515 
Notes: Correlation of Analyst EPS estimate percentage difference  
(dependent variable) with R & D percentage difference (independent variable) 
filtered on Analyst EPS estimate percentage > -100 and Analyst EPS estimate 
percentage < 100%. 
 
V.6 Hypothesis 4: A change in R&D expenditure impacts analysts’ EPS estimate 
forecasts for the following year.   
The correlation results (Table 23) are positive for the next year estimate, with a 
coefficient value at .021; the significance is slightly above .05, with a sample size of 
6,515.  Although results for the next year are better than the current year, the hypothesis 
cannot be confirmed as the significance is greater than .05.  
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Similar to the regression test for analyst sales estimate forecasts to confirm the 
correlation results, regression tests were performed for analyst EPS estimate differences 
as the dependent variable and R&D expenditure difference, gross margin, assets log, 
revenue difference, and long-term debt/sales as the independent variables.   
The regression results (Table 24) for all IT companies using R&D difference, gross 
margin, asset logs, revenue difference, and long-term debt/sales associated with analysts’ 
EPS estimate differences show that research spending standard coefficient beta is 
negative, but the value is not significant. The revenue difference has the highest positive 
standard coefficient beta value, with .000 significance. 
Table 24 Regression of R&D, Revenue, … with Analyst EPS Estimate 
















.023 .000 24.15 -
.023/.113 
-.011/.000 .093/.000 .124/.000 -.011/.431 
Next year 
estimate 
.072 .000 83.86 -
.035/.013 
-.027/.037 .131/.000 .246/.000 -.021/.116 
Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst 
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100%. 
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We removed revenue difference from the regression testing to understand 
research spending’s influence on the regression in the absence of the revenue difference 
variable. As Table 25 shows, the standard coefficient beta value was positive but not 
significant. The next year estimate is .023, with .06 significance, and the R2 values are 
quite small.   
Table 25 Regression of R&D, … with Analyst EPS Estimate (Without Revenue) 











.005 .000 7.220 .009/.493 -.017/.191 -.014/.263 -.014/.263 
Next year 
estimate 
.010 .000 15.89 .023/.060 -.016/.197 .099/.000 -.028/.029 
Notes : Regression of  independent variables (R&D percentage difference, 
gross margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate 
percentage difference(dependent variable) filtered on Analyst EPS estimate % > -
100% and Analyst EPS estimate < 100% 
I conducted market segmentation analysis to understand how analysts’ EPS 
estimate difference is associated with R&D difference for various market sizes. As noted 
earlier, the data was filtered for analysts’ EPS estimate percentage difference greater than 
–100 percent and less than 100 percent. The current year results illustrate (Table 26) that 
the correlation is positive and significant for large and midsized companies, with .134 
and .050, respectively; for companies with less than $1 billion in market capitalization, 
the correlation is not significant.   
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However, reviewing results for the next year shows a standard coefficient beta 
value of .223 for large, .133 for medium, and .055 for small companies, and a 
significance value for all three segments of less than .01 with the next year analyst EPS 
estimate as an independent variable.  The current year sample sizes for large, medium, 
and small companies are 404, 1,533, and 3,370, respectively, with next year sample sizes 
of 405, 1,558, and 3,425, respectively.   
Table 26 Correlation of R&D with Analyst EPS – Market Cap Segmentation 
Years Market value Pearson 
Correlation 
Sig N 
Current year Estimate >=10 billion .134 .007 404 
Current year Estimate >1 billion & <10billion .050 .051 1533 
Current year Estimate =< 1 billion .013 .457 3370 
Next year Estimate >=10 billion .223 .000 405 
Next year Estimate >1 billion & <10billion .133 .000 1558 
Next year Estimate =< 1 billion .055 .001 3425 
Notes: Market capitalization wise Correlation of Analyst EPS estimate 
percentage difference(dependent variable) with R & D percentage difference 
(independent variable) filtered on Analyst EPS estimate percentage difference > -
100% and < 100%. 
Regression results for large companies (Table 27) show R2 at 11 percent for 
current year and 9 percent for next year.  The standard coefficient beta value for research 
spending is negative and not significant; the revenue difference standard coefficient beta 
is .386 and .384 for the current and next year, respectively, with less than .01 
significance.   
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Table 27 Regression of R&D, Revenue, … with Analyst EPS Estimate (Large Size 
companies) 
















.119 .000 10.24 -
.076/.222 
-.048/.328 .008/.886 .386/.000 -.017/.726 
Next year 
estimate 





Notes: Regression of independent variables (R&D percentage difference, gross 
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS 
estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for companies with market 
capitalization > 10 billion. 
 
The regression test (Table 28) was performed using four constructs: research 
spending difference, gross margin, assets log, and long-term debt/sales; revenue 
difference was not included as it had a strong influence in the previous regression test. 
The results from the regression without the revenue difference reveal that R2 for the 
current and next year is 2 percent and 5 percent, respectively.  The research difference 
standard coefficient beta for companies with market capitalization of more than $10 
billion has positive values of .114 and .206 for the current and next year, respectively.  
The significance for both years is less than .05 mean, while other independent variables 
in this regression have significance greater than .05. 
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Table 28 Regression of R&D, … with Analyst EPS Estimate, Large Size companies 
(No Revenue) 











.022 .075 2.142 .114/.036 .035/.491 -.068/.209 .001/.986 
Next year 
estimate 
.053 .000 5.470 .206/.000 .029/.563 -.049/.353 -.029/.563 
Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets),  Long-term debt/sales) with Analyst EPS estimate 
percentage difference (dependent variables) filtered on Analyst EPS estimate % > -
100% and Analyst EPS estimate < 100% for companies with market capitalization 
>= 10 billion. 
 
Midsized companies regression results (Table 29) follow the same pattern as large 
companies: standard coefficient beta value for research spending is negative and not 
significant, whereas the revenue difference standard coefficient beta is at .386 and .384 
for the current and next year, respectively, with significance less than .01. The R2 for the 
current year and next year are .02 and .05 respectively. The gross margin is positive, with 





Table 29 Regression of R&D, Revenue, … with  Analyst EPS Estimate (Medium 
Size companies) 




























Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst 
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for companies with market 
capitalization < 10 billion and market capitalization > 1 billion. 
 
Results without revenue difference for midsized companies indicate (Table 30) 
that research spending for the current year is not significant; however, the standard 
coefficient of research spending for next year is significant, with the coefficient value at 
.106. The R2 is weak when regression is run without the revenue difference: the R2 is 2 





Table 30 Regression of R&D...  with Analyst Sales Estimate, (Medium Size 
companies)(No Revenue) 











.022 .000 8.292 .026/.329 .024/.35 -1.697/.09 -.045/.090 
Next year 
estimate 
.039 .000 15.71 .106/.000 .031/.21 -.146/.000 .003/.921 
Notes: Regression of independent variables (R&D percentage difference, gross 
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS 
estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for companies with market 
capitalization < 10 billion and market capitalization > 1 billion. 
 
The last category for the regression study under the market capitalization is for 
small market capitalization companies (Table 31). The regression results pattern is the 
same here as for large and midsized companies: the standard coefficient values of 
research spending are negative, with significance slightly above .05 for the current and 
next years.  As in the results for the large and midsized companies, the revenue difference 






Table 31 Regression of R&D, Revenue, … with  Analyst EPS Estimate ( Small Size 
companies) 




























Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst 
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for companies with market 
capitalization <= 1 billion. 
 
In Table 32, the regression results without revenue difference for small companies 
demonstrate that the R2 and F values are weak for both years. The research spending 
standard coefficient beta is .05, with significance less than .01; however, for the current 






Table 32 Regression of R&D… with Analyst EPS Estimate (Small Size companies) 
(No Revenue) 











.006 .001 4.605 .011/.521 -.015/.393 -.071/.000 .023/.189 
Next year 
estimate 
.004 .000 3.706 .054/.002 -.022/.200 -.026/.140 -.007/.682 
Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets),  Long-term debt/sales) with Analyst EPS estimate 
percentage difference (dependent variables) filtered on Analyst EPS estimate % > -
100% and Analyst EPS estimate < 100% for companies with market capitalization 
<= 1 billion. 
 
The next set of results is based on industry grouping.  I performed correlation 
tests to understand the association of R&D spending with analysts’ EPS estimate 
revisions and how the results vary for different industry groups.  Correlation results for 
sales demonstrated a positive correlation, with a significance of less than .01.  However, 
reviewing the EPS results (Table 33) shows that only the Semiconductor industry 
grouping has a positive correlation of .078 for the current year and .017 for the next year, 
with a significance of less than .05.  The other industry results show positive correlation, 




Table 33 Correlation of R&D with Analyst EPS – Industry Group Segmentation 





Software and Services 
(4510) 
.014 .486 2555 
Current year 
Estimate 
Technology Hardware and 
equipment (4520) 






.078 .003 1475 
Next year 
Estimate 
Software and Services 
(4510) 
.036 .072 2568 
Next year 
Estimate 
Technology Hardware and 
equipment (4520) 






.110 .000 1492 
Notes: Industry wise Correlation of Analyst EPS estimate percentage difference 
(dependent variable) with R & D percentage difference (independent variable) 
Analyst EPS estimate % > -100% and Analyst EPS estimate < 100%.  
The next six tables (34 to 39) show regression results of analysts’ EPS estimate 
percentage difference based on industry segmentation.  As with other EPS tests, the data 
is filtered by analysts’ EPS estimate to avoid the outliers with extreme values. The same 
pattern is observed in research spending, with a negative standard coefficient beta value 
for the Software and Services industry group for both years and values that are not 
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significant (Table 34). The revenue difference standard coefficient is positive at .115 and 
.214 for the current year and next year, respectively, with less than .01 significance. The 
R2 values are 2 percent and 6 percent for the current and next years, respectively, whereas 
F values are 8 and 28, respectively. 
Table 34 Regression of R&D……with Analyst EPS Estimate (Software and Services 
companies) 
















.021 .000 8.46 -
.028/.226 
-.004/.873 .094/.000 .115/.000 .001/.949 
Next year 
estimate 
.066 .000 28.89 -
.035/.139 
-.049/.021 .145/.000 .214/.000 .035/.114 
Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst 
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for software and services 
industry group. 
 
Software and Services regression results without revenue difference (Table 35) 
reveal that the research spending standard coefficient for next year is positive at .044, 
with significance below .05. The current year result is not significant even though values 
are positive. The R2 values are quite weak for both years, and the F values are 2 and 11 
for the current and next year. 
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Table 35 Regression of R&D……with Analyst EPS Estimate (Software and service 
companies) (No Revenue) 











.005 .000 2.976 .015/.446 -.012/.555 .067/.001 .003/.882 
Next year 
estimate 
.018 .000 11.20 .044/.026 -.041/.039 .115/.000 .024/.000 
Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate 
percentage difference (dependent variables) filtered on Analyst EPS estimate % > -
100% and Analyst EPS estimate < 100% for software and services industry group. 
 
Technology Hardware and Equipment regression results reveal a negative 
standard coefficient for research spending, which is significant as the values are less than 
.01 for the current year and .06 for the next year. Revenue difference is positive at .150 
and .260 for the current and next year, with less than .01 significance.  The R2 values are 
2 percent and 8 percent for the current and next year, respectively, and the F values are 






Table 36 Regression of R&D……with Analyst EPS Estimate (Technology Hardware 
companies) 
















.029 .000 11.4 -
.067/.006 
-.031/.167 .103/.000 .150/.000 -.007/.763 
Next year 
estimate 
.080 .000 35.89 -
.043/.060 
-.002/.916 .133/.000 .260/.000 .133/.000 
Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst 
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for technology hardware 
industry group. 
 
In Table 37, results without the revenue spending difference for Technology 
Hardware and Equipment companies’ show that the standard coefficient is not 
significant. In this regression, the assets log seems to have a positive standard coefficient 
with a significance of less than .05.   Similar to other regressions without revenue, the R2 





Table 37 Regression of R&D……with Analyst EPS Estimate (Technology hardware 
companies) (No Revenue) 











.005 .018 2.969 .004/.851 -.022/.284 .071/.001 -.013/.539 
Next year 
estimate 
.014 .000 8.542 .018/.362 .018/.374 .101/.000 -.07/.001 
Notes: Regression of independent variables (R&D percentage difference, 
gross margin, Log(Assets),  Long-term debt/sales) with Analyst EPS estimate 
percentage difference (dependent variables) filtered on Analyst EPS estimate % > -
100% and Analyst EPS estimate < 100% for technology hardware industry group. 
 
Semiconductor Equipment regression results (Table 38) also have revenue 
difference as a strong influence, with the standard coefficient at .306 and .284 for the 
current year and the next year, respectively, and a significance of less than .01.  The 
research spending values are not significant for both years and the R2 value is 9 percent 







Table 38 Regression of R&D……with Analyst EPS Estimate (Semiconductor 
companies) 























.090 .000 25.99 -
.015/.596 
-.028/.286 .119/.000 .284/.000 -.029/.291 
Notes: Regression of independent variables (R&D percentage difference, gross 
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS 
estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for semiconductor industry 
group. 
 
Regression results for the Semiconductor industry group without the revenue 
spending difference show a positive standard coefficient value for research spending, 
with a significance of less than .01. The research spending has the most influence in these 
regression results, with standard coefficient values at .075 and .116 for the current and 
next year, respectively. When compared with other industries, this research spending 





Table 39 Regression of R&D……with Analyst Sales Estimate (Semiconductor 
companies)(No Revenue) 











.011 .003 4.069 .075/.004 -.020/.438 .07/.010 -.031/.255 
Next year 
estimate 
.021 .000 7.930 .116/.000 .028/.274 .088/.001 -.024/.377 
Notes: Regression of independent variables (R&D percentage difference, gross 
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS 
estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for semiconductor industry 
group. 
 
Analysis for R&D expenditure more than 5 percent 
In their study on long-term abnormal stock returns and operating performance following 
R&D increases, Eberhart, Maxwell, and Siddque (2004) used companies with research 
spending greater than 5 percent as their sample data. Their study found consistent 
evidence of abnormal stock returns experienced by the firm shareholders following the 
R&D increases.  They also observed positive long-term abnormal operating performance 
following their R&D increases and suggested that the market is slow to recognize the 
extent of this benefit. One of their sample criteria for selecting data for their study was a 
5 percent increase in R&D.  My sample data was generated by filtering the data for 
research spending greater than 5 percent; I then ran correlation and regression tests 
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against this generated sample data. Tables 40 to 44 show the results of these tests: the 
sample sizes for R&D spending percentage greater than 5 percent are 4,241 and 4,176, 
for the current year and next year, respectively, whereas the complete sample without the 
filter of 5 percent was 6,830 for the current year and 6,690 for the next year.  So, using 
the data filter reduced the sample size by 38 percent for both the current and next year.   
The correlation results (Table 40) for all companies with research spending greater than 5 
percent year over year shows a positive correlation, with .201 and .167 for the current and 
next year, respectively, and a significance of less than .01 for both years. The correlation 
results were positive for all companies, with values at .153 and .183 for the current and 
next year, respectively (Table 13). 






Current year estimate All IT .201 .000 4241 
Next year estimate ALL IT .167 .000 4176 
Notes: Correlation of Analyst sales estimate percentage difference  (dependent 
variable) with R & D percentage difference (independent variable) filtered on 
Analyst EPS estimate percentage > -100 and Analyst EPS estimate percentage < 
100% for R&D spending difference year over year > 5%. 
 
The regression results (Table 41) for all companies using the same constructs as 
in my earlier tests demonstrates that the standard coefficient beta for research spending is 
.310 and .146 for current year and next year, respectively, with a significance of less than 
.01. The values of research spending difference are higher than revenue spending 
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difference.  The standard coefficient values for research spending for all IT companies 
without the R&D spending filter were .221 and .159 for the current and next year, 
respectively (Table 14).   
Table 41 Regression of R&D, Revenue……with Analyst Sales Estimate with R&D 
increase > 5% 
















.130 .000 111.3 .310/.000 .078/.000 .128/.000 .098/.000 -.018/.184 
Next year 
estimate 
.057 .000 43.15 .146/.000 .007/.654 .131/.000 .123/.000 .000/.977 
Notes : Regression of  Independent variables (R&D expenditure percentage 
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term 
debt/sales) with Analyst sales estimate percentage difference (dependent variable) 
filtered on R&D spending difference year over year > 5%. 
 
The correlation results (Table 42) for analysts’ EPS estimate percentage 
difference compared to R&D percentage difference shows that the correlation is not 
significant in either year.  These results are consistent with the results for all IT 





Table 42 Correlation R&D with Analyst EPS Estimate for R&D increase > 5% 
Years Sector description Pearson 
Correlation 
Sig N 
Current year estimate All IT .005 .726 4217 
Next year estimate All IT .016 .281 4304 
Notes: Correlation of Analyst EPS estimate percentage difference  (dependent 
variable) with R & D percentage difference (independent variable) filtered on 
Analyst EPS estimate percentage > -100 and Analyst EPS estimate percentage < 
100% for on R&D spending difference year over year > 5%. 
 
Regression results (Table 43) for analysts’ EPS estimate percentage difference 
with the independent variables (research spending, gross margin, assets log, revenue 
difference, and long-term debt/sales) shows that, for the current year, the correlation in 
not significant, while for the next year, it is negatively correlated with a value of –.047 
and a significance of less than .01.   The correlation results for all IT companies (Table 
24) for the current year is not significant, while the next year value is –.035.   The 
revenue difference (Table 43) has a positive standard coefficient with a significance of 
less than .01.  The R2 values are 3 percent and 8 percent and the F values are 26 and 61 






Table 43 Regression of R&D, Revenue……with Analyst EPS Estimate for R&D 
increase > 5%. 
















.039 .000 26.70 -
.029/.104 
-.008/.000 .147/.000 .141/.000 -.028/.115 
Next year 
estimate 
.081 .000 61.09 -
.047/.007 
-.031/.053 .157/.000 .250/.000 -.008/.625 
Notes: Regression of independent variables (R&D percentage difference, gross 
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS 
estimate percentage difference (dependent variables) filtered on Analyst EPS 
estimate % > -100% and Analyst EPS estimate < 100% for on R&D spending 
difference year over year > 5%. 
 
I performed the regression again by removing the revenue difference construct for 
the R&D spending difference of greater than 5 percent year over year. The research 
spending standard coefficient values are not significant (Table 44), the R2 values for both 







Table 44 Regression of R&D……with Analyst EPS Estimate (No Revenue) filtered 
for R&D increase > 5% 












.011 .000 12.21 .008/.600 -.020/.202 .110/.000 -.033/.038 
Next year 
estimate 
.013 .000 13.86 .020/.913 -.018/.227 .115/.000 -.018/.240 
 
Notes: Regression of independent variables (R&D percentage difference, gross 
margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate percentage 
difference (dependent variables) filtered on Analyst EPS estimate % > -100% and 





VI CHAPTER 6: DISCUSSION 
After reviewing the correlation test results for all the IT companies, I found that R&D 
expenditure has a positive correlation with analysts’ sales estimates.   These results are 
consistent for the current year and the next year, but the next year results show higher 
correlation than the current year.  The correlation results for analysts’ EPS estimates and 
R&D expenditure are different than for the analysts’ sales estimate correlation results. 
The results for all IT companies show that the R&D spending and the analysts’ EPS 
estimates do not have a significant correlation.  The next year correlation values are close 
to significant, and they improved from the current year correlation values. 
The regression results for all IT companies using the independent variables (R&D 
expenditure difference percentage, gross margin, assets log, revenue difference, long-
term debt/sales) and the dependent variable (analysts’ sales estimate percentage 
difference) reveal a strong R2 for both years and a significant positive standard 
coefficient beta for both years.  The revenue and assets have a significant standard 
coefficient beta for both years, whereas the research spending standard coefficient 





Summary of all Correlation of analyst sales and EPS with R&D 
Table 45 Consolidated Correlation of R&D with Analyst Sales and EPS Revision 
 Current/Next Data filtered on Correlation Sig N Supporting  
Hypothesis 
Sales Current year All IT companies .153 .000 6860 Yes 
  >=10 billion .569 .000 421 Yes 
  >1 billion & <10billion .350 .000 1685 Yes 
  =< 1 billion .128 .000 4502 Yes 
   Software and Services  .210 .000 2719 Yes 
   Technology Hardware and 
equipment  
.088 .000 2458 Yes 
   Semiconductor  .136 .000 1683 Yes 
  R&D spending percentage 
> 5 
.201 .000 4241 Yes 
 Next year All IT companies .183 .000 6690 Yes 
  >=10 billion .479 .000 421 Yes 
  >1 billion & <10billion .361 .000 1674 Yes 
  =< 1 billion .102 .000 3969 Yes 
  Software and Services  .205 .000 2657 Yes 
  Technology Hardware and 
equipment 
.211 .000 2369 Yes 
  Semiconductor and 
Semiconductor equipment 
.120 .000 1664 Yes 
  R&D spending percentage 
> 5 
.167 .000 4176 Yes 
 75 
EPS Current year All IT companies .008 .536 6387 Not Significant 
  >=10 billion .134 .007 404 Yes 
  >1 billion & <10billion .050 .051 1533 Yes 
  =< 1 billion .013 .457 3370 Not Significant 
   Software and Services  .014 .486 2555 Not Significant 
   Technology Hardware and 
equipment  
.004 .844 2388 Not Significant 
   Semiconductor  .078 .003 1475 Yes 
  R&D spending percentage 
> 5 
.005 .726 4217 Not Significant 
 Next year All IT companies .021 .084 6515 Not Significant 
  >=10 billion .223 .000 405 Yes 
  >1 billion & <10billion .133 .000 1558 Yes 
  =< 1 billion .055 .001 3425 Yes 
  Software and Services  .036 .072 2568 Not Significant 
  Technology Hardware and 
equipment 
.017 .390 2476 Not Significant 
  Semiconductor and 
Semiconductor equipment 
.110 .000 1492 Yes 
  R&D spending percentage 
> 5 
.016 .281 4304 Not Significant 
 
The same correlation tests that were executed for analyst sales estimates and R&D 
spending difference were performed for the first 10 years to observe analysts’ pattern of 
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revising analyst sales and EPS estimates.  Table 46 shows the results for the first 10 years 
(1995–2004).  The results for next 10 years (2005–2014) are captured in Table 47.  
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Summary of all Correlation of analyst sales and EPS with R&D for first 10 years 
Table 46 Consolidated Correlation of R&D with Analyst Sales and EPS Revision for 
first 10 years (1995 – 2004) 
 Current/Next Data filtered on Correlation Sig N Supporting  
Hypothesis 
Sales Current year All IT companies .232 .000 3280 Yes 
  >=10 billion .584 .000 153 Yes 
  >1 billion & <10billion .370 .000 625 Yes 
  =< 1 billion .208 .000 2050 Yes 
   Software and Services  .361 .000 1369 Yes 
   Technology Hardware and 
equipment  
.093 .000 1238 Yes 
   Semiconductor  .144 .000 673 Yes 
  R&D spending percentage 
> 5 
.223 .000 2063 Yes 
 Next year All IT companies .221 .000 3145 Yes 
  >=10 billion .473 .000 153 Yes 
  >1 billion & <10billion .385 .000 614 Yes 
  =< 1 billion .138 .000 1884 Yes 
  Software and Services  .251 .000 1319 Yes 
  Technology Hardware and 
equipment 
.230 .000 1167 Yes 
  Semiconductor and 
Semiconductor equipment 
.162 .000 659 Yes 
  R&D spending percentage 
> 5 
.200 .000 2010 Yes 
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Summary of all Correlation of analyst sales and EPS with R&D for last 10 years 
Table 47 Consolidated Correlation of R&D with Analyst Sales and EPS Revision for 
first 10 years (2005 – 2014) 
 Current/Next Data filtered on Correlation Sig N Supporting  
Hypothesis 
Sales Current year All IT companies .046 .006 3580 Yes 
  >=10 billion .247 .000 268 Yes 
  >1 billion & <10billion .278 .000 1060 Yes 
  =< 1 billion .02 .343 2119 Not Sig 
   Software and Services  .009 .744 1350 Yes 
   Technology Hardware and 
equipment  
.132 .000 1220 Yes 
   Semiconductor  .130 .000 1010 Yes 
  R&D spending percentage 
> 5 
.070 .000 2192 Yes 
 Next year All IT companies .108 .000 3545 Yes 
  >=10 billion .258 .000 268 Yes 
  >1 billion & <10billion .320 .000 1060 Yes 
  =< 1 billion .062 .005 2085 Yes 
  Software and Services  .093 .001 1338 Yes 
  Technology Hardware and 
equipment 
.201 .000 1202 Yes 
  Semiconductor and 
Semiconductor equipment 
.065 .039 1005 Yes 
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  R&D spending percentage 
> 5 
.075 .000 2179 Yes 
 
VI.1 Correlation analysis 
A review of all of the companies in Table 45 shows a strong correlation that 
supports Hypothesis 1.   
 
Hypothesis 1: A change in R&D expenditure impacts analysts’ sales estimate 
forecasts for the current year.   
The market capitalization segmentation analysis shows that correlation strength 
varies depending on company size: large companies have a strong positive correlation, 
midsized companies have a positive correlation, and small companies have a relatively 
weak correlation.  Srinivasan’s (2007) study shows the contingent effect of a firm’s 
advertising and R&D expenditures on the dispersion in analysts’ forecast of earnings, 
suggesting that analysts pay attention to firms’ marketing activities.  Srinivasan further 
adds that firms with a record of past performance, have decreased dispersion in analyst 
forecasts.  Typically, large and midsized companies have been in business longer and 
have past experience that gives analysts more confidence when they update their 
estimates.   The greater the firm’s R&D expenditure, the lower the support for dispersion 
in analysts’ forecast hypotheses (Srinivasan 2007).    Over the past two decades, smaller 
firms have begun allocating more money to R&D (see Table 48).  Hirschey et al. (2012) 
discuss how the R&D share is being distributed among large, medium, and small 
companies. For example, companies that Hirschey et al. ranked above 1,000 spent more 
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than $1 billion on R&D in 2010.  (Their data does not include financial or utility 
companies.)  
Table 48 Distribution of R&D Spending 
(Hirschey et al) 
 
From a comparative review of industry segmentation, the Software and Services 
group has a stronger positive correlation than the Technology Hardware or 
Semiconductor groups, but all three industry groups are positively correlated. In a 2014 
Market Realist article, Hirschey et al. discuss the software company cost structure of IT 
companies, noting that the majority of their operating expenditures consist of R&D costs 
and marketing spending.  With the emergence and adoption of cloud computing and open 
source software, companies are finding it very difficult to maintain the high margins once 
associated with the industry (Market Realist, 2014). They note that software companies 
spend more on R&D investment to differentiate those products that are hard to replicate 
or that are protected by intellectual property rights or patents.  Patents serve as armor for 
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software companies.  Small companies and start-ups find patents hard to penetrate; 
establishing a strong customer base makes switching costs very high and adds to the 
challenges of start-ups.   
As per Bloomberg’s data, between 2013 and 2014, the Internet companies Google 
and Amazon increased their R&D spending by 17 and 43 percent, respectively; hardware 
companies IBM and Cisco increased their R&D spending by –1.2 and 8.3 percent, 
respectively; and the Semiconductor company Intel increased its R&D spending by 4.6 
percent.   The growth of cloud technology, which has impacted hardware companies’ 
revenues for the past decade, has not given analysts the confidence to update that sector’s 
forecast. As other researchers have noted, past performance of companies decreases 
dispersion in analyst forecasts (Srinivasan, 2007).  In my analysis of companies that have 
increased their R&D spending by 5 percent, I found a strong positive correlation between 
R&D spending and analyst sales estimate revisions for the current year.  
Hypothesis 2: A change in R&D expenditure impacts analysts’ sales estimate 
forecasts for the next year.   
I ran correlation and regression tests for only one year following the current year; 
testing beyond that reduces the analyst forecast quality.  The O'Brien study (1988) 
compares consensus analyst forecasts with time-series forecasts from one- to four-
quarters ahead.  The analyst forecasts outperform the time-series model for one- and two-
quarter-ahead forecasts, are approximately the same for three-quarter ahead forecasts, and 
perform worse for four-quarter ahead forecasts.  Thus, the advantage analysts gain from 
firm-specific information seems to deteriorate as the time horizon for forecasting is 
 82 
extended.  In valuation, the focus is more on long-term growth rates in earnings than on 
next quarter's earnings.  There is little evidence to suggest that analysts provide superior 
earnings forecasts when those forecasts span three or five years.  An early study by 
Malkiel & Cragg (1980) compared long-term forecasts by five investment management 
firms in 1962 and 1963 with actual growth over the following three years; they concluded 
that analysts were poor long-term forecasters. 
In my study, the correlation for next year is positive in all categories: for all IT 
companies, it was slightly higher and, for hardware companies, the next year correlation 
was higher than the current year. Another noticeable result was that, in the smaller 
companies, the next year correlation is not as strong as the current year. The fact that the 
analyst forecasts are not accurate over the longer term might be due to other unknown 
factors, such as interest rate changes and industry-specific fluctuations. These 
characteristics that are not firm-specific impact long-term analyst forecasts, which 
reduces the correlation for smaller companies as they often lack the past performance 
information that analysts use to update their next year estimates.  Fairfield, Ramnath, and 
Yohn (2009) describe how industry-specific models generate more accurate forecasts of 
sales growth in firms because “firms’ sales growth depends on product demand, which 
are determined at the industry level.” 
Hypothesis 3: A change in R&D expenditure impacts analysts’ EPS estimate 
forecasts for the current year.   
When reviewing the correlation between analysts’ current year EPS estimates and 
R&D expenditures for all companies, the results are not significant.  The companies with 
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more than $10 billion market value show positive correlation, as do midsized companies 
(between $1 billion and $10 million in market value), whereas the correlation is not 
significant with smaller companies. This might be due to various other expenses that 
impact the EPS, despite a positive correlation with the sales. For example, Company A 
might increase its R&D budget and see sales increase in the current year or next year, but 
expenses such as additional marketing expenses or hiring more customer service personal 
to support the new products might impact the EPS and hence analysts might not change 
the EPS based on R&D expenditure revisions.   
Past performance of the companies can also influence analyst updates of the EPS.  
Large and midsized companies with more of an R&D history might inspire analysts to 
modify the EPS estimates.   Semiconductor companies show a positive correlation here, 
whereas Software and Services and Technology Hardware and Equipment companies do 
not show significant results.  
Hypothesis 4: A change in R&D expenditure impacts analysts’ EPS estimate 
forecasts for the following year.   
The next year results for analysts’ EPS estimate forecasts are much better than the 
current year results.  This is because other costs associated with products are reduced as 
the years go by, so analysts increase the earnings. When comparing for companies with 
market cap greater than $10 billion, the correlation value is .223—much higher than the 
current year value of .134. Midsized companies show a next year correlation value of 
.133, compared to a current year value of .050. For small capitalization companies, the 
next year results show a positive correlation compared to the current year, where the 
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results were not significant.  In terms of industry groups, Technology Hardware 
correlation for the next year is not significant; the values are similar to the current year. 
As with the current year, Software and Services results are not significant for the next 
year, though the significance value is lower at .07. For the Semiconductor industry, the 
correlation results for the next year are higher than the current year, but both are 
positively correlated.   The correlation results for R&D spending greater than 5 percent 
over the previous year is not significant.   
Table 49 Correlation Summary of All Tests, Year Wise View 
 Sales  EPS  
 Current year 
Ear 
Next year Current year Next year 
All IT companies .153 .183 Not Sig Not Sig 
>=10 billion .569 .469 .134 .223 
>1 billion & <10billion .350 .361 .050 .133 
=< 1 billion .128 .102 Not Sig .055 
Software and Services  .210 .205 Not Sig Not Sig 
Technology Hardware and 
equipment  
.088 .211 Not Sig Not Sig 
Semiconductor  .136 .120 .078 .110 
R&D spending percentage > 5 .201 .167 Not Sig Not Sig 
Notes : Correlation summary of R&D difference to Analyst sales and EPS estimate 
changes. 
Table 49 consolidates the summary of all correlation results.  As a review of this 
table shows, Hypothesis 1 and Hypothesis 2 are strongly supported.  Hypotheses 3 and 4 
are not significant for all tests, but Hypothesis 4 has better results than Hypothesis 3.  
Givoly, Hayn, and D’Souza’s (1999) study shows that there is a stronger correlation 
between firm sales and industry sales than between firm profits and industry.  Sales 
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increases are not impacted by other expenses that normally impact the EPS, such as 
interest expenses and tax law changes.   So, R&D spending has direct association with 
the sales estimate, whereas for the EPS is impacted by many other factors. 
It is also clear that the current year sales correlation results are stronger than the 
next year’s results, but for EPS, the next year correlation results are stronger than the 
current year. This phenomenon is due to the fact that R&D spending by IT might show 
revenue benefit the same year as the IT industry is moving at a rapid pace.  The next year 
EPS results are better because the current year includes additional marketing and training 
costs to launch the product; these costs reduce in the years that follow. 
When I analyzed the results for first 10 years and compared them with next 10 
years, I noticed a change in analyst’s behavior. The decade wise results were gathered by 
running correlation tests for the analyst sales estimate difference with R&D spending 
changes.  Table 50 shows the results from both tests. These decade wise results are 
compared against the test results from 20 years. 
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Table 50 Correlation tests for analyst sales estimate with R&D decade wise 
compared with 20 years data 




1995 - 2014 
Sale
s 
Current year All IT companies .232 .046 .153 
  >=10 billion .584 .247 .569 
  >1 billion & <10billion .370 .278 .350 
  =< 1 billion .208 Not Sig .128 
   Software and Services  .361 .009 .210 
   Technology Hardware 
and equipment  
.093 .132 .088 
   Semiconductor  .144 .130 .136 
  R&D spending 
percentage > 5 
.223 .070 .201 
 Next year All IT companies .221 .108 .183 
  >=10 billion .473 .258 .479 
  >1 billion & <10billion .385 .320 .361 
  =< 1 billion .138 .062 .102 
  Software and Services  .251 .093 .205 
  Technology Hardware 
and equipment 
.230 .201 .211 
  Semiconductor and 
Semiconductor equipment 
.162 .065 .120 
  R&D spending 
percentage > 5 
.200 .075 .167 
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The results for the decade from 1995–2004 illustrate that the next year correlation 
results are lower than the current year results; however, for midsized companies, the 
Technology Hardware and Semiconductor industries’ next year results are higher than the 
current year.  The results for 1995–2004 follow the same pattern as the 20-year 
correlation results, except for IT and semiconductor companies.   
My analysis also showed that the pattern for 2005–2014 was different than that 
for 1995–2004.  The correlation results for 2005–2014 are positive, but they are much 
lower than the 1995–2004 results.  Also the results indicate that the next year results for 
2005–2014 are higher than current year results.  Based on these results, there is strong 
evidence that the R&D spending differences in the past decade (2005–2014) are 
associated more with the next year analyst sales estimate revisions than those of the 
current year.   
VI.2 Regression Analysis 
I performed regression analysis using the five independent variables (R&D 
expenditure difference percentage, gross margin, assets log, revenue difference, and long-
term debt/sales) and the analysts’ sales estimate percentage difference as the dependent 
variable. For sales and EPS regression tests, R&D, revenue, and assets log had significant 
positive standard coefficient, while gross margin and long-term debt/sales did not. 
 
Hypothesis 1: A change in R&D expenditure impacts analysts’ sales estimate 
forecasts for the current year.   
I analyzed regression results to see if Hypothesis 1 is supported by R&D changes.  For all 
IT companies, R2 is .07 and the standard coefficient beta is positive.  Segment analysis 
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shows that, for market capitalization greater than $10 billion, the R2 is .65 and R&D is 
not significant, but the revenue coefficient is high at .839. For midsized companies, R2 is 
.50 and, similar to large companies, the revenue coefficient is high.  Based on this 
information, I conclude that the revenues are influencing the regression.  For large 
companies, the revenue changes are not volatile and R&D spending change influences 
will be low.  For small companies, the R&D standard coefficient is positive at .217, 
whereas the revenue is not significant.  Also, revenue changes are volatile for small 
companies, and quite hard to predict, hence the R&D has a greater influence in analysts’ 
sales estimate changes. 
Studying industry group segmentation shows that Software and Services and 
Technology Hardware and Equipment have a positive standard coefficient for R&D 
expenditure changes.  Semiconductor revenue, however, shows a higher coefficient in the 
regression. As the Bloomberg report showed, Software and Services companies like 
Google spend more on R&D, and hence analysts are influenced to increase their sales 
estimates over their revenue estimates.  The same report showed that Cisco, a 
Technology Hardware Company, increased its R&D by a high single digit, whereas the 
Semiconductor company Intel increased it by only 4 percent. Analysts reviewing the 
percentage increase of R&D spending are influenced by the industry practice of R&D 
spending, and will use the latter to update their sales estimate.   
For companies with abnormal R&D increases, the R&D year-over-year standard 
coefficient is .310 compared to .098 for revenue difference. This result shows that, the 
higher the R&D increase, the more likely analysts are to change their sales forecasts.  
Based on my analysis of these regression, I conclude that Hypothesis 1 is supported by 
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the regression test results, even though some results showed that revenue has a 
considerable influence.   
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Summary of all regression of Analyst sales and EPS estimate with R&D 
Table 51 Consolidated Regression of R&D with Analyst Sales and EPS Revision 
 Current 
/Next 





All IT companies .075 98 .221 .092 Asset 
  >=10 billion .65 150 Not 
Sig 
.839  
  >1 billion & <10billion .50 299 Not 
Sig 
.722  
  =< 1 billion .05 42 .217 Not Sig Asset 
   Software and Services  .08 42 .235 .106 Asset 
   Technology Hardware and 
equipment  
.07 35 .195 Not sig Asset, Gross 
Margin 
   Semiconductor  .51 112 Not 
Sig 
.494 Asset 
  R&D spending percentage 
> 5 
.13 111 .310 .098 Asset 
 Next 
year 
All IT companies .069 87 .159 .142 Asset 
  >=10 billion .38 48 Not 
sig 
.636  




  =< 1 billion .02 17 .103 Not Sig Asset 
  Software and Services  .12 60 .168 .229 Asset 
  Technology Hardware and 
equipment 
.06 27 .195 Not Sig Asset, Gross 
Margin 
  Semiconductor and 
Semiconductor equipment 
.16 62 Not 
Sig 
.390 Asset 
  R&D spending percentage 
> 5 
.06 43 .146 .123 Asset 
EPS Current 
year 
All IT companies .02 24 Not 
Sig 
.124 Asset 
  >=10 billion .12 10 Not 
Sig 
.386  
  >1 billion & <10billion .07 20 -.132 .284 Asset (-), 
Gross Margin 
  =< 1 billion .01 8 Not 
Sig 
.101  
   Software and Services  .02 8 Not 
Sig 
.115 Asset 
   Technology Hardware and 
equipment  
.02 11 -.067 .150 Asset 
   Semiconductor  .09 25 Not 
Sig 
.306  
  R&D spending percentage 
> 5 






All IT companies .07 83 -.035 .246 Asset 
  >=10 billion .09 8 Not 
Sig 
.304 Asset 
  >1 billion & <10billion .15 50 -.138 .449 Gross Margin 
  =< 1 billion .04 26 Not 
Sig 
.209  
  Software and Services  .06 29 Not 
Sig 
.214 Asset 
  Technology Hardware and 
equipment 
.08 36 Not 
Sig 
.260 Asset 
  Semiconductor and 
Semiconductor equipment 
.09 26 Not 
Sig 
.284 Asset 
  R&D spending percentage 
> 5 




Hypothesis 2: A change in R&D expenditure impacts analysts’ sales estimate 
forecasts for the next year.   
Next year regression results (Table 51) are similar to current year regression results. The 
tests that had a positive standard coefficient for the current year also had a positive 
standard coefficient for the next year. The next year’s standard coefficient is slightly less 
than the current year results.  As I noted earlier, the O'Brien study (1988) confirms that 
analyst forecasts that are more than four quarters ahead are worse than those derived 
using the time-series model.  Other macro and industry factors impact analysts’ sales 
estimates for the next year.  For example, Skyworks Solutions Company, a supplier to 
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Apple, might increase its R&D spending, but if Apple revenue is expected to reduce due 
to China’s slowing growth, analysts might not increase their sales estimate forecasts for 
Skyworks.  The next year results show that, for large companies, midsized companies, 
and Technology Hardware companies, the revenue independent variable influences the 
regression more than R&D expenditures.  Thus, when comparing the next year values, 
the revenue coefficient is slightly lower than the current year.  
R&D spending increases of more than 5 percent have a positive standard coefficient for 
all companies and a greater influence on regression than on revenue.  Out of eight 
regression tests, five show that R&D has bigger influence on the regression than the 
revenue, with a positive coefficient. These results support Hypothesis 2—that R&D 
expenditure change impacts analysts’ next year sales estimate forecasts. 
 
Hypothesis 3: A change in R&D expenditure impacts analysts’ EPS estimate 
forecasts for the current year.   
Analyst EPS regression results for all IT companies—using analysts’ EPS estimate 
forecasts as the dependent variable—show that R&D spending differences have little 
influence on the regression.  However, regression test results show that revenue 
spending’s standard coefficient is positive and has as strong influence on regression.  
Further, analysts take other costs into consideration, and hence will be unlikely to modify 
their EPS estimate.  For example, strong competition requires more spending on 
marketing the product, which impacts the bottom line and might prevent analysts from 
modifying their EPS estimates.  Also, companies typically hire customer service reps to 
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support new products, and this cost also impacts the bottom line and might be another 
reason why analysts are hesitant to update EPS estimates. 
I performed regression without the revenue as a dependent variable, while 
keeping the other four independent variables and the analysts’ EPS estimate revisions as 
the dependent variable. The results (Table 52) show that, for large and midsized market 
capitalization companies, the R&D change is significant, with a positive standard 
coefficient. In the Semiconductor group, companies have a positive standard coefficient. 
For all these tests, the R2 and F values are quite low. Thus, regarding Hypothesis 3, the 
regression test shows that revenue is a strong influencer on analysts’ EPS estimates, but 
when revenue is removed from the regression, three out of eight tests demonstrate a 
positive standard coefficient. Thus, hypothesis 3 is partially supported when revenue is 
not part of the regression.   
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Summary of all regression of Analyst EPS estimate with R&D, without 
Revenue 




Data filtered on R2 F R&D 
EPS Current year All IT companies .005 7.2 Not Sig 
  >=10 billion .02 2.1 .114 
  >1 billion & <10billion .02 8.2 .026 
  =< 1 billion .01 7.8 Not Sig 
   Software and Services  .00 2.9 Not Sig 
    Technology Hardware and equipment  .00 2.9 Not Sig 
   Semiconductor  .01 4.0 .07 
  R&D spending percentage > 5 .01 12.21 Not Sig 
 Next year All IT companies .01 15 Not Sig 
  >=10 billion .05 .00 .206 
  >1 billion & <10billion .04 15 .106 
  =< 1 billion .00 3.7 .054 
  Software and Services  .01 11 .044 
  Technology Hardware and equipment .01 8.5 Not Sig 
  Semiconductor and Semiconductor 
equipment 
.02 .00 7.9 




Hypothesis 4: A change in R&D expenditure impacts analysts’ EPS estimate 
forecasts for the following year.   
EPS next year regression test results (Table 51) are similar to the current year 
regression results: revenue difference has more influence in the regression for all eight 
tests and R&D is not significant; where it is significant, the values are negative standard 
coefficients.  The same reasons as for current year analysts’ using revenue over R&D 
apply for the next year test results. I reran regression without revenue, keeping other 
independent variables, to understand the behavior of R&D change on the regression.  
Results show that, in three out of eight tests, the R&D differences had a positive standard 
coefficient for the next year.  Five out of the eight tests had a positive standard 
coefficient, while the next year results had a higher coefficient than the previous year’s 
values.   
Large capitalization company values were .206, while midsized capitalization 
company values were .106. The current year values were .114 for large companies and 
.026 for midsized companies.  I also found a significant increase in the coefficient in the 
next year results.  The values of small companies and software companies were not 
significant in the current year, but have a positive standard coefficient in the next year.  
As  stated in the correlation analysis, analysts modify EPS estimates based on R&D 
differences in the: previous year. Analyst are recognizing that R&D spending in large 
companies is based on past R&D investment experiences and their impact on the 
company’s financial results.   
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Regression summary of R&D difference to Analyst sales and EPS estimate changes. 
Table 53 Regression Summary of All Tests, Year Wise View 















All IT companies .221 .159 Not Sig -.035 Not Sig Not Sig 
>=10 billion Not Sig Not sig Not Sig Not Sig .114 .206 
>1 billion & <10billion Not Sig Not sig -.132 -.138 .026 .106 
=< 1 billion .217 .103 Not Sig Not Sig Not Sig .054 
Software and Services  .235 .168 Not Sig Not Sig Not Sig .044 
Technology Hardware and 
equipment  
.195 .195 -.067 Not Sig Not Sig Not Sig 
Semiconductor  Not Sig Not Sig Not Sig Not Sig .07 7.9 
R&D spending percentage 
> 5 
.310 .146 Not Sig Not Sig Not Sig Not Sig 
 
Table 53 shows all the results, summarizing all of the regression tests in a single 
snapshot.  The regression results are similar to correlation in terms of sales estimate 
revisions: five out of the seven tests are supported in the current and next year results. 
The pattern of R&D impact on analysts’ sales estimates reduces in the next year, which 
matches the pattern observed in analysts’ sales estimate revisions and R&D difference 
correlation results.  Based on the earlier observations, I conclude that hypotheses 1 and 2 
are supported.  Summarizing analysts’ EPS estimates shows no significance for R&D 
difference in the regression, and revenue difference is the primary influencer on the 
estimates. When I remove revenue difference from the regression, large, midsized, and 
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Semiconductor companies’ R&D change results are significant; the past R&D 
performance of these companies influence analysts’ to update their EPS estimates. A 
January 2009 survey conducted by the US National Science Foundation and the US 
Census Bureau found that companies with fewer than 500 employees accounted for 11 
percent of worldwide sales for all US companies, but 19 percent of research spending.  
Companies with more than 25,000 employees accounted for 42 percent of global sales, 
but just 36 percent of research outlays. These very small companies (those with 5 to 24 
employees) spent $3 billion—that is, at least 50 percent more than all other small firms 
(those with fewer than 500 employees)—in payments to others to do research. The tinest 
of the companies also had the most research ($5 billion worth) paid for by 
others (Courtney Rubin, Inc., 2009). 
Even though the large companies with more than 25,000 employees are smaller in 
number, they account for 36 percent of the total research spending.  Companies gradually 
increase their research spending; for large companies, this creates a trail of past 
performance that lets analysts revise their estimates based on R&D spending over time.   
The next year results for EPS estimate revision impact shows five positive coefficients, 
and their values are higher than the current year, which follows the pattern of EPS 
correlation results.  Regression patterns match correlation patterns when the results are 
compared year over year.  The current year results in sales estimate regression are 
stronger than the next year results; however, for EPS estimates, the regression without 
revenue difference shows stronger next year results than current year results. R&D 
revisions that impact analysts’ sales revisions for IT companies are seen in the same year, 
while analysts’ EPS estimate changes due to R&D revisions are seen in the next year due 
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to the additional costs involved in launching a new product. Table 54 shows the results of 
the Hirschey et al. study that compared research spending changes from 1976 to 2010.  
Although smaller companies are spending more, the number of firms that spent less than 
$25 million increased by 53 percent, while large ($250 million or more in spending) and 
midsized companies (between $25 and $250 million) showed 490 percent and 134 
percent growth, respectively.  
Table 54 Number of R&D Firms  
(Hirschey et al, 2012) 
 
Table 55 shows the results of Hirschey et al.’s study in terms of R&D spending to 
total earnings as reported by the top 100 R&D spenders, the next 100 largest, and so on.  





Table 55 Earnings of R&D Firms  
(Hirschey et al, 2012) 
 
VI.3 Summary of Hypothesis Results 
Table 56 Summary of Hypothesis Results 
 Correlation Regression Regression without 
Revenue difference 
Hypothesis 1 Supported Supported  
Hypothesis 2 Supported Supported  
Hypothesis 3 Supported Not Significant Partially Supported 
Hypothesis 4 Supported Not Significant Supported 
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Table 56 summarizes the hypothesis findings in the correlation and regression 
tests.   Hypotheses 1 and 2 are supported by both correlation and regression.  Hypotheses 
3 and 4 are supported by correlation testing.  During regression testing, when the revenue 
difference variable is removed, Hypothesis 4 is supported and Hypothesis 3 is partially 
supported.  
VI.4 Contribution to Practice 
This study finds a statistically significant relationship between the changes in 
R&D spending and analysts’ sales estimate forecasts. Although there is strong belief in 
the industry that R&D spending impacts company revenues, analysts recognize the 
benefits of R&D differently based on a company’s size and IT sector.  Further, analysts 
update their sales and EPS estimates in different ways for the current and the next year.  
This research breaks down the relationship between the R&D spending and analysts’ 
sales estimate revisions and EPS estimate revisions using 20 years’ worth of IT sector 
data.  Practitioners, company leaders and chairmen, and chief executive officers (CEOs) 
can review this report when making decisions about R&D spending. Previous studies 
have proven a strong correlation between analyst revisions of company revenue and 
earnings to stock price movement. Top managers at all firms are interested in increasing 
their stock price..  This research paper will help the CEOs and chief financial officers 
(CFOs) of IT companies make decisions about how to allocate R&D expenditures for 
their company in a way that benefits them in both the short and long term.  
As these research results show, a strong correlation exists between R&D spending and 
analysts’ sales estimates, and how the EPS revisions increase next year over current year 
based on R&D spending.  The economic significance of the estimates is large.  I find that 
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analysts typically adjust their EPS estimates in a range of about 5-30 percent of the 
percentage change in R&D expenditures.   So if R&D expenditures were to change by 
50%, for example, analyst EPS revisions would change by about 2.5 to 15 percent.  This 
understanding is especially important for small companies, since they have fewer market 
participants who follow their stock. 
Companies that are planning to diversify from one industry to another can also 
benefit from this research, including hardware companies that are planning to move into 
the software business.  IBM, which is a primarily a hardware company, has moved into 
the software industry over the past two decades. Companies wanting to take the path of 
IBM or vice versa can review this report to get an overview of their R&D allocation to 
different segments.   
Finally, companies that are growing in market capitalization can benefit from this 
study, which can help them understand how R&D spending impacts the analysts’ 
estimates in sales and earnings.  
VI.5 Contribution to Theory 
My study fills a gap in the literature by examining how analysts use R&D 
expenditures to adjust their sales and EPS estimates.  In theory, increased R&D should 
lead to increased sales, which should translate to increased earnings.   Academic research 
has traditionally focused on R&D spending and its impact on earnings.  For example, 
Chan et al.’s study (2001) focused on R&D spending’s financial impact on high-tech 
companies.  My paper is the first to shed light on how analysts perceive the linkage 
between R&D, sales, and earnings.  In so doing, I provide the bridge to other strands of 
the R&D and analyst literature.  One of these strands is the relationship between C-level 
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executives’ compensation and R&D spending. Another is a line of literature that links 
analyst estimates and their impact on stock price.  
While Keung (2010) has discussed the importance of analyst forecast sales and 
earnings forecast revisions, little research has been done on R&D and analysts’ estimates, 
and none has studied R&D spending and its impact on analysts’ sales and EPS estimates. 
This research helps to fill that academic gap by examining companies’ R&D expenditures 
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